PMCID,title,journal,pubDate
7286676,A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques,Science Advances,06-10
7426916,A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation,Nature Communications,08-13
7499300,"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity",Nature Communications,09-17
7836858,"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","Lancet (London, England)",07-20
7832443,"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial",The Lancet. Infectious Diseases,11-17
7314147,Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients,Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America,06-04
7292504,The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries,"Science (New York, N.y.)",06-12
7323511,Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients,Emerging Infectious Diseases,07-01
7095418,A pneumonia outbreak associated with a new coronavirus of probable bat origin,Nature,02-03
7074197,Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data,Journal of Clinical Medicine,02-17
7153529,An Infectious cDNA Clone of SARS-CoV-2,Cell Host & Microbe,04-13
7289564,"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","Lancet (London, England)",06-11
7449230,Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates,The New England Journal of Medicine,07-28
7299279,Broad neutralization of SARS-related viruses by human monoclonal antibodies,"Science (New York, N.y.)",06-15
7674972,"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial","Lancet (London, England)",11-19
7556339,Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults,The New England Journal of Medicine,09-29
7164679,"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model","Science (New York, N.y.)",04-17
7202686,Development of an inactivated vaccine candidate for SARS-CoV-2,"Science (New York, N.y.)",05-06
7270802,"COVID-19: Emergence, Spread, Possible Treatments, and Global Burden",Frontiers in Public Health,05-28
7300195,Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development,Frontiers in Immunology,06-11
7091888,Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine,Cellular and Molecular Immunology,03-19
7243363,DNA vaccine protection against SARS-CoV-2 in rhesus macaques,"Science (New York, N.y.)",05-20
7569573,WHO Declares COVID-19 a Pandemic,Acta Bio Medica : Atenei Parmensis,03-19
7121626,SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients,The New England Journal of Medicine,03-19
7159299,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","Lancet (London, England)",01-24
7319273,A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2,"Science (New York, N.y.)",06-22
7442695,Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals,Nature,06-18
7327103,Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy,Frontiers in Pharmacology,06-24
7319493,Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome,Science Immunology,06-26
7471804,"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia","Lancet (London, England)",09-04
7159018,An interactive web-based dashboard to track COVID-19 in real time,The Lancet. Infectious Diseases,02-19
7239918,Immunogenicity of a DNA vaccine candidate for COVID-19,Nature Communications,05-20
7187672,"The trinity of COVID-19: immunity, inflammation and intervention",Nature Reviews. Immunology,04-28
7199733,Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies,Cell,05-05
7135076,"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","Lancet (London, England)",01-30
7114094,The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade,Antiviral Research,02-10
7195694,Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset,JAMA Internal Medicine,05-01
7094941,The SARS-CoV-2 Vaccine Pipeline: an Overview,Current Tropical Medicine Reports,03-03
7402625,Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques,"Science (New York, N.y.)",07-02
7658622,Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis,EClinicalMedicine,11-12
7427556,Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19,Cell,08-14
7524645,Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike,Cell Reports. Medicine,09-30
7377258,An mRNA Vaccine against SARS-CoV-2 — Preliminary Report,The New England Journal of Medicine,07-14
7445431,"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial","Lancet (London, England)",08-15
7302472,"Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020",Morbidity and Mortality Weekly Report,06-19
7164637,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,"Science (New York, N.y.)",02-19
7584426,NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge,Vaccine,10-23
7745181,Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine,The New England Journal of Medicine,12-10
7706979,"Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020",Emerging Infectious Diseases,12-01
7787219,Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine,The New England Journal of Medicine,12-30
7723445,"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","Lancet (London, England)",12-08
7545019,"COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland",Intensive Care Medicine,10-09
7473321,High neutralizing antibody titer in intensive care unit patients with COVID-19,Emerging Microbes & Infections,07-20
7121484,"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia",The New England Journal of Medicine,03-26
7172901,"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial",The Lancet. Infectious Diseases,04-21
7230578,"The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control",Journal of Clinical Medicine,04-24
7136867,SARS-CoV-2 Vaccines: Status Report,Immunity,04-06
7159286,A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,"Lancet (London, England)",01-24
7270627,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","Lancet (London, England)",03-11
7437502,"SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential",Cell Reports. Medicine,08-19
7048180,Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody,Emerging Microbes & Infections,02-17
7581537,SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness,Nature,08-05
7299280,Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model,"Science (New York, N.y.)",06-15
7094943,A new coronavirus associated with human respiratory disease in China,Nature,02-03
7332439,Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus,Cell,07-03
7120970,Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany,The New England Journal of Medicine,03-05
7081172,The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application,Annals of Internal Medicine,03-10
7159086,Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding,"Lancet (London, England)",01-30
7014672,"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020",Eurosurveillance,02-06
7243369,SARS-CoV-2 infection protects against rechallenge in rhesus macaques,"Science (New York, N.y.)",05-20
7275151,"Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2",Cell,06-06
7292605,A minimal common outcome measure set for COVID-19 clinical research,The Lancet. Infectious Diseases,06-12
7364749,Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in,Cell Research,07-07
7323562,High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2,Emerging Infectious Diseases,07-01
7561304,"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial",The Lancet. Infectious Diseases,10-15
7581548,Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques,Nature,07-30
7250779,SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract,Cell,05-27
7081895,Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus,Journal of Virology,03-17
7361120,Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention,American Journal of Preventive Medicine,07-15
7092803,"A Novel Coronavirus from Patients with Pneumonia in China, 2019",The New England Journal of Medicine,02-20
7237901,Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals,Cell,05-20
7255193,"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","Lancet (London, England)",05-22
7494251,Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine,The New England Journal of Medicine,09-02
7167841,Lessons unfolding from pediatric cases of COVID‐19 disease caused by SARS‐CoV‐2 infection,Pediatric Pulmonology,04-03
7247514,"Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines",Vaccine,05-25
7102627,SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor,Cell,03-05
7725513,"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020",Morbidity and Mortality Weekly Report,03-27
7583697,Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates,The New England Journal of Medicine,10-14
7144318,Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2,Emerging Microbes & Infections,03-24
7195331,"First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment","Lancet (London, England)",04-08
7484573,Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods,Journal of Biomolecular Structure & Dynamics,08-04
7484575,screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein  an approach to prevent virus assembly,Journal of Biomolecular Structure & Dynamics,08-27
7296090,Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside,Frontiers in Cell and Developmental Biology,06-09
7661101,Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins,European Journal of Clinical Microbiology & Infectious Diseases,11-12
7671939,Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters,Nature Medicine,09-03
7364217,Humoral Immunity to Hantavirus Infection,mSphere,07-15
7218962,An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development,Medical Science Monitor : International Medical Journal of Experimental and Clinical Research,05-05
7195434,Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis,Journal of Clinical Virology,04-14
7590269,Curcumin (a constituent of turmeric): New treatment option against COVID‐19,Food Science & Nutrition,09-06
7857392,Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome,Science Immunology,12-07
7730020,T‐cell responses and therapies against SARS‐CoV‐2 infection,Immunology,10-27
7767099,SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus,Viruses,12-18
7688518,Current and Future Direct-Acting Antivirals Against COVID-19,Frontiers in Microbiology,11-12
7547570,Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies,Biochemical and Biophysical Research Communications,10-10
7298161,Overview of therapeutic drug research for COVID-19 in China,Acta Pharmacologica Sinica,06-17
7571161,The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents,Molecules,09-07
7317891,"Door to the cell for COVID-19 opened, leading way to therapies",Signal Transduction and Targeted Therapy,06-26
7772801,ACE2: the molecular doorway to SARS-CoV-2,Cell & Bioscience,12-30
7380256,Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy,Virus Research,07-24
7232534,Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2,Viruses,04-10
7399623,"Identify the Risk Factors of COVID-19-Related Acute Kidney Injury: A Single-Center, Retrospective Cohort Study",Frontiers in Medicine,07-28
7121452,Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19,The New England Journal of Medicine,03-30
7462629,SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies,Asian Journal of Pharmaceutical Sciences,09-01
7605515,"Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic",Human Vaccines & Immunotherapeutics,10-29
7538152,Myocardial injury in a patient with severe coronavirus disease: A case report,Journal of Infection and Chemotherapy,10-06
7280120,Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system,Biochemical and Biophysical Research Communications,06-09
7537588,Characteristics of SARS-CoV-2 and COVID-19,Nature Reviews. Microbiology,10-06
7427466,Medicinal Plants as Sources of Active Molecules Against COVID-19,Frontiers in Pharmacology,08-07
7399655,Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation,Journal of Molecular Liquids,08-04
7117595,Drug repurposing strategies for COVID-19,Future Drug Discovery,03-25
7228407,Diabetes is a risk factor for the progression and prognosis of ‐19,Diabetes/Metabolism Research and Reviews,04-07
7405773,COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans,"Infection, Genetics and Evolution",08-05
7490921,Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review,BMJ Open,09-14
7458862,"Current Status of Etiology, Epidemiology, Clinical Manifestations and Imagings for COVID-19",Korean Journal of Radiology,08-04
7194845,studies on therapeutic agents for COVID-19: Drug repurposing approach,Life Sciences,04-09
7470530,SARS-CoV-2: Should We Be Concerned about the Nervous System?,The American Journal of Tropical Medicine and Hygiene,07-17
7141637,"Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management",Clinical Gastroenterology and Hepatology,04-08
7724580,SARS-CoV-2 and COVID-19 “covidiosyncrasies” and their impact on endoscopists and endoscopy: Referring to Belle A et al. p. 1111–1115,Endoscopy,11-25
7668668,Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization,Molecular and Cellular Biochemistry,11-16
7359796,Association between COVID-19 and cardiovascular disease,International Journal of Cardiology. Heart & Vasculature,07-14
7510477,"Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease",PeerJ,09-01
7581855,Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection,Frontiers in Pharmacology,10-09
7452173,"ACE2, Metformin, and COVID-19",iScience,07-31
7778948,CoV3D: a database of high resolution coronavirus protein structures,Nucleic Acids Research,09-05
7189391,"Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",Coronavirus Disease 2019 (COVID-19),04-30
7553008,Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator,Acta Pharmaceutica Sinica. B,10-13
7645721,Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach,Scientific Reports,11-05
7347253,Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?,Critical Care,07-09
7332869,Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine,Journal of Biomolecular Structure & Dynamics,06-25
7775215,Assessment of Anxiety and Stress among Dental Students to Return to Training in Dental College in COVID-19 Era,European Journal of Dentistry,10-08
7156133,Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts,"Journal of Microbiology, Immunology, and Infection",03-14
7566707,Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease,JCI Insight,10-02
7219357,Rational Vaccine Design in the Time of COVID-19,Cell Host & Microbe,05-13
7543737,Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2,Toxicology Reports,10-08
7370630,A systematic review of neurological symptoms and complications of COVID-19,Journal of Neurology,07-20
7685319,An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19,bioRxiv,11-17
7757226,Coronavirus infection and kidney disease: a review of current and emerging evidence,The Pan African Medical Journal,10-13
7646266,Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipeline,Transboundary and Emerging Diseases,10-06
7408073,The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients,Cells,07-16
7608487,The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET,Pathogens and Immunity,10-19
7332889,Scoring systems for predicting mortality for severe patients with COVID-19,EClinicalMedicine,07-03
7373131,Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization,bioRxiv,07-15
7484565,Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19,Human Vaccines & Immunotherapeutics,08-26
7412965,CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2,Frontiers in Microbiology,07-31
7236793,Prediction and analysis of key protein structures of 2019-nCoV,Future Virology,05-12
7372296,Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections,EBioMedicine,07-21
7568776,Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping,Journal of Immunology Research,10-17
7151266,Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence,Travel Medicine and Infectious Disease,04-02
7597597,Vaccines for COVID‐19,Clinical and Experimental Immunology,10-18
7410821,Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection,"Infection, Genetics and Evolution",08-07
7403850,Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission,The Science of the Total Environment,08-05
7455777,Central neurological complications and potential neuropathogenesis of COVID-19,Internal and Emergency Medicine,08-29
7362072,COVID‐19 and arterial hypertension: Hypothesis or evidence?,"Journal of Clinical Hypertension (Greenwich, Conn.)",07-06
7467038,Abdominal Surgery in Patients With COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues,Annals of Surgery,06-16
7724661,Prospective mapping of viral mutations that escape antibodies used to treat COVID-19,bioRxiv,12-01
7762169,Efforts at COVID-19 Vaccine Development: Challenges and Successes,Vaccines,12-06
7511214,Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations,mSystems,09-22
7395230,Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2,"Infection, Genetics and Evolution",08-01
7489987,SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2,Cell,09-14
7642257,Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology,Frontiers in Immunology,10-22
7667367,Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?,Brain and Behavior,09-16
7586267,New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release,Evolutionary Bioinformatics Online,10-23
7173822,"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study",The Lancet. Microbe,04-21
7745603,Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome?,Medical Science Monitor : International Medical Journal of Experimental and Clinical Research,12-13
7551685,Could Vitamins Help in the Fight Against COVID-19?,Nutrients,08-23
7330865,SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy,Theranostics,06-12
7309076,"Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen","Sensors (Basel, Switzerland)",05-31
7678433,Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with  and  approaches,Biochemical and Biophysical Research Communications,11-20
7735396,A historical perspective on ACE2 in the COVID-19 era,Journal of Human Hypertension,12-14
7310631,The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity,bioRxiv,06-12
7672574,"Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2",International Journal of Molecular Sciences,11-04
7405906,Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2,Life Sciences,08-05
7378481,The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong,Journal of Clinical Virology,07-24
7241105,Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual,bioRxiv,05-12
7266584,Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach,"Infection, Genetics and Evolution",06-02
7186931,Coronavirus jolts labs to warp speed,Nature Methods,04-17
7823949,Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19,Viruses,12-26
7506347,Myocarditis in athletes after COVID-19 infection: The heart is not the only place to screen,Sports Medicine and Health Science,09-22
7239220,"Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study",Clinical Kidney Journal,05-09
7799234,"Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective",Antibody Therapeutics,12-28
7269512,Updated Approaches against SARS-CoV-2,Antimicrobial Agents and Chemotherapy,05-21
7308593,"Immune Response, Inflammation, and the Clinical Spectrum of COVID-19",Frontiers in Immunology,06-16
7387075,The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts,Cureus,06-27
7463036,"Is oseltamivir suitable for fighting against COVID-19: In silico assessment,  and retrospective study",Bioorganic Chemistry,09-02
7833242,The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition,Journal of Molecular Biology,12-11
7857409,An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike,"Science (New York, N.y.)",11-05
7695554,"Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples",Journal of Immunological Methods,11-28
7397057,"Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts",Genes,07-07
7538938,Risk estimation of SARS-CoV-2 transmission from bluetooth low energy measurements,NPJ Digital Medicine,10-06
7189178,Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty,Current Cardiology Reports,04-29
7201274,Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19,IUCrJ,04-06
7568573,Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics,Scientific Reports,10-16
7771249,"Characterization of the SARS-CoV-2 S Protein:Biophysical, Biochemical, Structural, and Antigenic Analysis",ACS Omega,12-21
7744031,Slaying SARS-CoV-2 One (Single-Domain) Antibody at a Time,Trends in Microbiology,12-16
7594953,Identification of SARS-CoV-2 entry inhibitors among already approved drugs,Acta Pharmacologica Sinica,10-28
7605853,Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate,Matter,11-02
7685322,The Development of a Novel Nanobody Therapeutic for SARS-CoV-2,bioRxiv,11-17
7730245,Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein,Materials,11-26
7144809,Diagnosing COVID-19: The Disease and Tools for Detection,ACS Nano,03-30
7402234,Structure of the Pandemic,"Structure (London, England : 1993)",08-04
7166309,Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop,Journal of Molecular Biology,04-19
7568492,Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects,International Journal of Biological Macromolecules,10-17
7309308,Identification of bioactive compounds from  as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study,Journal of Biomolecular Structure & Dynamics,06-18
7757116,SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?,Oxidative Medicine and Cellular Longevity,12-21
7232909,COVID-19: Current Knowledge and Best Practices for Orthopaedic Surgeons,Indian Journal of Orthopaedics,05-18
7837099,Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus,Vaccine,07-11
7376845,Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2,Eurosurveillance,07-16
7386171,Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein,Genome Medicine,07-28
7228352,Facing the COVID‐19 outbreak: What should we know and what could we do?,Journal of Medical Virology,03-05
7668221,Synthesis of potentially new schiff bases of -substituted-2-quinolonylacetohydrazides as anti-COVID-19 agents,Journal of Molecular Structure,11-16
7794730,Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements,International Journal of Molecular Sciences,12-23
7332874,"Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets",Journal of Biomolecular Structure & Dynamics,06-24
7799217,Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19,Briefings in Bioinformatics,12-21
7152864,Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence,Journal of Quantitative Spectroscopy & Radiative Transfer,04-13
7449962,Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms,Scientific Reports,08-26
7263503,An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations,bioRxiv,05-21
7604330,The SARS-CoV-2 spike protein: balancing stability and infectivity,Cell Research,11-02
7366990,The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity,Cell,07-17
7457919,Nanomedicine strategies to target coronavirus,Nano Today,08-31
7480032,"The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2",bioRxiv,09-04
7193306,Does COVID-19 Spread Through Droplets Alone?,Frontiers in Public Health,04-24
7473855,An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction,Nature Communications,09-04
7555793,Smoking and COVID-19: Adding Fuel to the Flame,International Journal of Molecular Sciences,09-09
7441844,A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization,Infection,08-21
7501874,Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system,Microbes and Infection,09-19
7199908,Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir,"Science (New York, N.y.)",05-01
7471564,Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research,Journal of Neurovirology,09-03
7515807,Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System,Current Treatment Options in Neurology,09-25
7239618,The immunology of COVID-19: is immune modulation an option for treatment?,The Lancet Rheumatology,05-20
7500502,Flavonoids: A complementary approach to conventional therapy of COVID-19?,Phytochemistry Reviews,09-18
7217073,"Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor  and  in Inflammatory Bowel Disease",Gastroenterology,05-12
7416703,Approaches and Challenges in SARS-CoV-2 Vaccine Development,Cell Host & Microbe,08-10
7787036,Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review,Medical Journal of the Islamic Republic of Iran,09-17
7745171,"Clinical characteristics of 41 patients with pneumonia due to 2019 novel coronavirus disease (COVID-19) in Jilin, China",BMC Infectious Diseases,12-17
7640897,Insights from nanotechnology in COVID-19 treatment,Nano Today,11-04
7328712,Coronavirus disease 2019 (COVID-19): latest developments in potential treatments,Drugs in Context,06-29
7563410,Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis,Microorganisms,08-26
7372174,"and  expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19",Journal for Immunotherapy of Cancer,07-15
7661926,Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen,Biosensors & Bioelectronics,11-13
7150947,Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies,Viruses,02-25
7642679,Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area,mBio,10-30
7544447,"Sars-CoV-2, de nouvelles données",Revue Francophone Des Laboratoires,10-08
7265355,Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig,Nature Communications,04-24
7256487,Ethical rationale for better coordination of clinicalresearch on COVID-19,Research Ethics,05-28
7232917,Molecular Targets in the Chemotherapy of Coronavirus Infection,Biochemistry. Biokhimiia,05-18
7719853,"Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Province, China",BMC Infectious Diseases,12-07
7381222,Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review,Frontiers in Microbiology,07-14
7708895,Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis,European Journal of Medical Research,12-02
7759632,SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses,Frontiers in Pharmacology,12-11
7457604,Theoretical basis for stabilizing messenger RNA through secondary structure design,bioRxiv,08-24
7191115,Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection,The European Respiratory Journal,06-04
7320251,COVID-19: Current Trends in Invitro Diagnostics,Indian Journal of Clinical Biochemistry,06-27
7857391,Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity,"Science (New York, N.y.)",10-20
7589738,Use of Yoghurt Enhanced with Volatile Plant Oils Encapsulated in Sodium Alginate to Increase the Human Body’s Immunity in the Present Fight Against Stress,International Journal of Environmental Research and Public Health,10-19
7784663,Biomaterials-Based Opportunities to Engineer the Pulmonary Host ImmuneResponse in COVID-19,ACS Biomaterials Science & Engineering,12-27
7737396,Computational Insights into the Conformational Accessibilityand Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-ConvertingEnzyme 2,The Journal of Physical Chemistry Letters,12-04
7676316,Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition,Cell Host & Microbe,11-19
7565175,Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein–Drug and Protein–Protein Structures: An Analysis of Kinetically Active Residues,Biomolecules,09-21
7375304,Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics,Biophysical Chemistry,07-22
7307180,The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development,Journal of Virology,06-16
7706175,SARS coronavirus 2: from genome to infectome,Respiratory Research,12-01
7231725,Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells,Cell,05-18
7533733,Electrolyte Disturbances in SARS-CoV-2 Infection,F1000Research,07-22
7675679,Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2,Nano Select,10-12
7098030,SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat,International Journal of Biological Sciences,03-15
7584627,A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone,Scientific Reports,10-23
7685342,Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response,medRxiv,11-16
7337839,The Impact of SARS-Cov-2 Virus Infection on the Endocrine System,Journal of the Endocrine Society,07-02
7710351,2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease,Chemico-Biological Interactions,12-02
7798825,Potential benefits of dietary seaweeds as protection against COVID-19,Nutrition Reviews,12-22
7361741,Characteristics and serological patterns of ‐19 convalescent plasma donors: optimal donors and timing of donation,Transfusion,07-06
7474083,Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein,NPJ Vaccines,09-04
7691692,N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects,Journal of Clinical Immunology,11-27
7754975,Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment,ESC Heart Failure,09-16
7682383,Structure-based identification of potential SARS-CoV-2 main protease inhibitors,Journal of Biomolecular Structure & Dynamics,11-19
7857405,Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity,"Science (New York, N.y.)",09-29
7265107,Mechanistic inferences from clinical reports of SARS-CoV-2,"Infectious Diseases (London, England)",05-27
7450684,From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses,Respiratory Research,08-27
7799256,Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species,Briefings in Bioinformatics,12-08
7482545,Nanoparticle-Based Strategies to Combat COVID-19,ACS Applied Nano Materials,08-25
7217234,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,bioRxiv,04-09
7405498,Opportunities for biomaterials to address the challenges of ‐19,Journal of Biomedical Materials Research. Part a,08-04
7373143,Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform,Research Square,07-17
7640961,Repurposing ofFDA-Approved Toremifene to Treat COVID-19by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2,Journal of Proteome Research,09-10
7294866,Comparing the Binding Interactions in the Receptor Binding Domainsof SARS-CoV-2 and SARS-CoV,The Journal of Physical Chemistry Letters,06-01
7418720,Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity,bioRxiv,08-03
7328648,Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2,Virus Research,07-01
7361641,Revisiting potential druggable targets against ‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review,Drug Development Research,07-06
7805444,Immunological memory to SARS-CoV-2 assessed for up to eight months after infection,bioRxiv,12-18
7546614,Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein,NPJ Vaccines,10-08
7659516,Coagulopatía en la infección por el virus SARS-CoV-2 (COVID-19): De los mecanismos fisiopatológicos al diagnóstico y tratamiento,Acta Colombiana de Cuidado Intensivo,11-12
7395593,Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies,Biomedicine & Pharmacotherapy,08-01
7272904,SARS‐CoV‐2 immunogenicity at the crossroads,Allergy,05-25
7158802,Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China,Chest,04-15
7405882,"Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2",The Science of the Total Environment,08-05
7467095,Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus,Phytomedicine,09-02
7599121,Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review,Sn Comprehensive Clinical Medicine,10-31
7128678,Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection,International Journal of Antimicrobial Agents,04-03
7426626,Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS,Frontiers in Pediatrics,08-07
7753617,Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis,British Journal of Clinical Pharmacology,12-18
7457614,MMGB/SA Consensus Estimate of the Binding Free Energy Between the Novel Coronavirus Spike Protein to the Human ACE2 Receptor.,bioRxiv,08-26
7191310,The many faces of the anti-COVID immune response,The Journal of Experimental Medicine,04-30
7443692,Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor,Cell Host & Microbe,08-24
7144664,A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization,Biochemical and Biophysical Research Communications,04-09
7289715,Overview of lethal human coronaviruses,Signal Transduction and Targeted Therapy,06-10
7089213,Back to the spring of Wuhan: facts and hope of COVID-19 outbreak,Frontiers of Medicine,03-14
7366121,"Virology, pathogenesis, diagnosis and in-line treatment of COVID-19",European Journal of Pharmacology,07-17
7733686,Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection,Advanced Drug Delivery Reviews,12-13
7540743,Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2,Royal Society Open Science,09-16
7430593,A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry,Research Square,08-14
7113464,Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic,Asian Spine Journal,03-30
7857411,Preexisting and de novo humoral immunity to SARS-CoV-2 in humans,"Science (New York, N.y.)",11-06
7786057,Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update,Frontiers in Cardiovascular Medicine,12-23
7267418,The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections,Journal of Medical Virology,05-17
7435302,"Principles for Managing Patients with Spinal Ailments in the Coronavirus Disease 2019 Era: What Do We Know So Far? An Evidence-Based, Narrative Review",Asian Spine Journal,06-05
7381314,BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?,Frontiers in Pharmacology,07-09
7250542,Can Zn Be a Critical Element in COVID-19 Treatment?,Biological Trace Element Research,05-26
7273036,Neurological Manifestations of COVID‐19: A systematic review and current update,Acta Neurologica Scandinavica,06-02
7734131,"Ocular Involvement in Coronavirus Disease 2019: Up-to-Date Information on Its Manifestation, Testing, Transmission, and Prevention",Frontiers in Medicine,11-30
7385064,Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan,Frontiers in Cellular and Infection Microbiology,07-21
7480804,Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications,"Hypertension (Dallas, Tex. : 1979)",08-27
7290261,A Case Series of Patients Coinfected With Influenza and COVID-19,Journal of Investigative Medicine High Impact Case Reports,06-10
7753300,COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces,International Journal of Laboratory Hematology,12-02
7462045,SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study,Thorax,09-11
7249615,Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?,Internal and Emergency Medicine,05-26
7266779,An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review,International Immunopharmacology,06-03
7590640,Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study,The Journal of Infection,10-27
7568509,Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran,New Microbes and New Infections,10-17
7301794,Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors,Virus Research,06-18
7529220,design of a potential inhibitor of SARS-CoV-2 S protein,PLoS ONE,10-01
7535071,Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions,AIMS Microbiology,09-24
7298165,Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses,Virologica Sinica,06-17
7755081,Discovery of High-Affinity Peptide Binders for theSARS-CoV-2 Spike Protein,ACS Central Science,12-17
7764473,Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival,Microbial Pathogenesis,12-26
7805603,Innate Immunity Plays a Key Role in Controlling Viral Load inCOVID-19: Mechanistic Insights from a Whole-Body Infection DynamicsModel,ACS Pharmacology & Translational Science,12-30
7447814,Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome,Scientific Reports,08-25
7188157,Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD,Inflammatory Bowel Diseases,04-25
7543042,analysis ofprotein/peptide-based inhalers against SARS-CoV-2,Future Virology,10-08
7648503,Unprecedented environmental and energy impacts and challenges of COVID-19 pandemic,Environmental Research,11-07
7139247,Coronavirus disease 2019 (COVID-19): current status and future perspectives,International Journal of Antimicrobial Agents,03-29
7395204,Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy,Chinese Journal of Integrative Medicine,08-01
7243210,Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review,Frontiers in Pediatrics,05-15
7137107,Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19,"Acta Crystallographica. Section D, Structural Biology",04-06
7286538,Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits,Science Translational Medicine,06-08
7302198,Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies,bioRxiv,05-29
7241398,Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2,Cell,05-21
7228347,Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures,Journal of Medical Virology,03-29
7203076,"Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus",Journal of Biosciences,05-07
7198092,New evidence of SARS-CoV-2 transmission through the ocular surface,Graefe's Archive for Clinical and Experimental Ophthalmology,05-04
7682976,Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology,Gastroenterology and Hepatology From Bed to Bench,09-20
7641529,"Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism",Computational Biology and Chemistry,11-04
7393334,Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19,Hypertension Research,07-31
7549344,Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection,Inflammation and Regeneration,10-12
7531490,A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy,mAbs,08-17
7685350,Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays,bioRxiv,11-18
7332464,Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection,Cell Reports,07-03
7543752,Spike protein-based epitopes predicted against SARS-CoV-2 through literature mining,Medicine in Novel Technology and Devices,10-08
7443335,"COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic",Life Sciences,08-23
7443330,Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development,Virus Research,08-23
7302211,CoV3D: A database and resource for high resolution coronavirus protein structures,bioRxiv,06-25
7334971,Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System,Advances in Chronic Kidney Disease,07-04
7579428,ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?,Frontiers in Molecular Biosciences,10-08
7402043,Engineered ACE2 receptor traps potently neutralize SARS-CoV-2,bioRxiv,08-04
7591510,Comparative ACE2 variation and primate COVID-19 risk,Communications Biology,10-27
7432953,"Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials",International Journal of Molecular Sciences,07-23
7323058,Infection Risk Assessment of COVID-19 through AerosolTransmission: a Case Study of South China Seafood Market,Environmental Science & Technology,06-16
7543791,Virus database annotations assist in tracing information on patients infected with emerging pathogens,Informatics in Medicine Unlocked,10-08
7338588,Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19,Frontiers in Immunology,06-30
7641315,Coronavirus rotational diffusivity,Physics of Fluids,11-01
7521454,Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials,International Journal of Biological Macromolecules,09-28
7351243,Rapid Structure-Based Screening Informs Potential Agents for Coronavirus Disease (COVID-19) Outbreak,Chinese Physics Letters,05-01
7576931,Repurposing of the approved small molecule drugs in order to inhibitSARS-CoV-2 S protein and human ACE2 interaction through virtual screeningapproaches,Journal of Biomolecular Structure & Dynamics,09-24
7384425,Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions,Cell Systems,07-27
7456593,Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications,"Engineering (Beijing, China)",08-30
7262043,We urgently need guidelines for managing COVID‐19 in children with comorbidities,"Acta Paediatrica (Oslo, Norway : 1992)",05-06
7609167,The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene,Immune Network,10-26
7706975,Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples,Emerging Infectious Diseases,12-01
7336130,Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination,Life Sciences,07-06
7654332,Technical Considerations to Development of Serological Tests for SARS-CoV-2,Talanta,11-10
7305708,COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking,Virus Research,06-20
7494848,Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country,Frontiers in Immunology,09-03
7556605,A materials-science perspective on tackling COVID-19,Nature Reviews. Materials,10-14
7174181,Innovations in structure-based antigen design and immune monitoring for next generation vaccines,Current Opinion in Immunology,04-22
7700726,Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors,"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences",11-29
7584425,Nano-targeting lessons from the SARS-CoV-2,Nano Today,10-23
7836893,Where are we with understanding of COVID-19?,Advances in Biological Regulation,07-21
7649230,Long-Term Modeling of SARS-CoV-2 Infection of  Cultured Polarized Human Airway Epithelium,mBio,11-06
7604864,Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges,Journal for Immunotherapy of Cancer,10-30
7346263,Impact of Thiol–Disulfide Balance on the Bindingof Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor,ACS Omega,06-23
7513931,Middle East Respiratory Syndrome (MERS) and novel coronavirus disease-2019 (COVID-19): From causes to preventions in Saudi Arabia,Saudi Pharmaceutical Journal : SPJ,09-24
7701115,Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration,Frontiers in Neurology,11-16
7656237,Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19,BioMed Research International,11-05
7558767,Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review,International Journal of Environmental Research and Public Health,09-14
7192319,COVID-19: Therapeutics and Their Toxicities,Journal of Medical Toxicology,04-30
7417266,"Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin",Heliyon,08-11
7672082,STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters,Nature Communications,11-17
7550166,Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes,Cell Reports,10-12
7256189,"New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention",Frontiers in Cell and Developmental Biology,05-22
7690584,The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies,Cells,10-22
7544937,Potential protease inhibitors and their combinations to block SARS-CoV-2,Journal of Biomolecular Structure & Dynamics,09-14
7551521,A systematic review of SARS-CoV-2 vaccine candidates,Signal Transduction and Targeted Therapy,10-13
7591873,Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?,International Journal of Infectious Diseases,10-28
7288791,Potential Mechanisms of Cardiac Injury and Common Pathways of Inflammation in Patients With COVID-19,Critical Pathways in Cardiology,05-27
7685317,AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics,bioRxiv,11-20
7587204,Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives,Molecules,10-11
7608010,Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope,International Immunopharmacology,11-03
7574912,Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2,"Science (New York, N.y.)",08-04
7418650,Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports,Respiratory Medicine Case Reports,08-11
7566897,Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis,Clinical Microbiology Reviews,10-14
7568783,Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region,Journal of Diabetes Research,10-08
7430581,Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering,bioRxiv,08-14
7271865,Extended use of face masks during the COVID-19 pandemic - Thermal conditioning and spray-on surface disinfection,Polymer Degradation and Stability,06-04
7668217,Sistema renina-angiotensina-aldosterona y COVID19. Implicaciones clínicas,Revista Española de Cardiología Suplementos,11-16
7211082,Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process,Gut,04-02
7536878,Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area,medRxiv,09-29
7071545,The Battle Against COVID-19: Where Do We Stand Now?,Iranian Journal of Medical Sciences,03-01
7440141,Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2Interactions,Analytical Chemistry,08-10
7267400,Comprehensive overview of ‐19 based on current evidence,Dermatologic Therapy,05-22
7263520,Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19,bioRxiv,07-31
7550876,"Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations",Epidemiology and Infection,09-29
7670925,Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies,Cell Host & Microbe,11-17
7523111,Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model,bioRxiv,09-17
7724663,Role of Long-range Allosteric Communication in Determining the Stability and Disassembly of SARS-COV-2 in Complex with ACE2,bioRxiv,12-01
7462411,"Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2",American Journal of Respiratory and Critical Care Medicine,09-01
7564940,Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection,Cells,09-08
7833638,Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles,Colloid and Interface Science Communications,12-26
7167229,Déjà vu: Stimulating open drug discovery for SARS-CoV-2,Drug Discovery Today,04-19
7737395,Molecular Dynamics Reveals Complex Compensatory Effectsof Ionic Strength on the Severe Acute Respiratory Syndrome Coronavirus2 Spike/Human Angiotensin-Converting Enzyme 2 Interaction,The Journal of Physical Chemistry Letters,12-03
7291041,Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays,Viruses,05-06
7192005,COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children,Frontiers in Pediatrics,04-23
7273175,Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19patients,Emerging Microbes & Infections,05-13
7413047,"Aerosol transmission of SARS-CoV-2? Evidence, prevention and control",Environment International,08-07
7301900,Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation,bioRxiv,06-12
7676326,Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics,Biochemical and Biophysical Research Communications,11-19
7260975,Cell entry mechanisms of SARS-CoV-2,Proceedings of the National Academy of Sciences of the United States of America,05-06
7455571,Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic,Phytomedicine,08-29
7199674,COVID-19: The first documented coronavirus pandemic in history,Biomedical Journal,05-05
7464562,Distinct conformational states of SARS-CoV-2 spike protein,"Science (New York, N.y.)",07-21
7332424,Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study,Diabetes Research and Clinical Practice,07-03
7509417,Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19,Frontiers in Immunology,09-04
7577971,Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein,Nature Communications,10-21
7264879,The Novel Coronavirus – Latest Findings,Microbial Biotechnology,05-03
7640983,Molecular Simulationsand Network Modeling Revealan Allosteric Signaling in the SARS-CoV-2 Spike Proteins,Journal of Proteome Research,10-02
7594191,"Prevention of SARS-CoV-2 cell entry: insight from  interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2",Journal of Biomolecular Structure & Dynamics,10-22
7351386,Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions,Journal of Taibah University Medical Sciences,07-10
7510013,The Perfect Storm: COVID-19 Health Disparities in US Blacks,Journal of Racial and Ethnic Health Disparities,09-23
7492024,Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant,Cell,09-15
7249572,Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise,Future Virology,05-26
7219836,The COVID-19 Pandemic Highlights Shortcomings in US Health Care Informatics Infrastructure: A Call to Action,Anesthesia and Analgesia,05-01
7146279,Spontaneous Hinge-Bending Motions of Angiotensin I Converting Enzyme: Role in Activation and Inhibition,Molecules,03-12
7651216,Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:  approaches,Journal of Biomolecular Structure & Dynamics,11-03
7571416,Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function,PeerJ,10-16
7513770,The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from,International Journal of Biological Macromolecules,09-24
7731341,Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study,Molecules,11-29
7648659,Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19,Stem Cell Reviews and Reports,11-07
7261073,The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway,Biochimie,05-30
7282781,Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach,Computers in Biology and Medicine,06-09
7529009,Guillain–Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient,Journal of Tropical Pediatrics,07-12
7274147,Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif theHallmark for Its Enhanced Infectivity? Insights from All-AtomSimulations,The Journal of Physical Chemistry Letters,05-28
7102599,"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein",Cell,03-09
7434851,Comparison of nonhuman primates identified the suitable model for COVID-19,Signal Transduction and Targeted Therapy,08-19
7771248,Natural Products with Potential to Treat RNA Virus Pathogens IncludingSARS-CoV-2,Journal of Natural Products,12-22
7444681,Neurological manifestations of COVID-19: available evidences and a new paradigm,Journal of Neurovirology,08-24
7343823,Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer,Communications Biology,07-08
7181998,Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2,Cell,04-24
7343650,Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment,Biosafety and Health,07-09
7668070,Engineered ACE2 receptor traps potently neutralize SARS-CoV-2,Proceedings of the National Academy of Sciences of the United States of America,10-22
7232184,Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs,Viruses,04-14
7290299,Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site,Journal of Clinical Medicine,05-14
7334636,Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies,Cellular and Molecular Life Sciences,07-04
7179544,Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade,Nephron. Clinical Practice,03-23
7366459,gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population,European Journal of Human Genetics,07-17
7308747,Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement,The Lancet. Gastroenterology & Hepatology,06-23
7583759,Peptides: Prospects for Use in the Treatment of COVID-19,Molecules,09-24
7687296,Computational Design of 25-mer Peptide Binders ofSARS-CoV-2,The Journal of Physical Chemistry. B,11-17
7698684,The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy,Biochemical and Biophysical Research Communications,11-28
7725053,FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein,Cell Host & Microbe,12-09
7575774,ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19,Frontiers in Immunology,10-07
7341686,Critical Differences between the Binding Features of the Spike Proteins ofSARS-CoV-2 and SARS-CoV,The Journal of Physical Chemistry. B,06-17
7832953,A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2,Environment International,12-23
7744049,A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody,PLoS Pathogens,12-04
7118693,"COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives",Trends in Molecular Medicine,03-21
7418704,Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding,Cell,08-11
7291340,"The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses",Viruses,05-22
7652766,A 21st Century Evil: Immunopathology and New Therapies of COVID-19,Frontiers in Immunology,10-27
7477069,Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications,Molecular Neurobiology,09-08
7239068,COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning,bioRxiv,03-21
7434624,Methods for making multiple alignment of genomic sequences for severe acute respiratory syndrome coronavirus 2,Meta Gene,08-19
7731011,Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2,International Journal of Molecular Sciences,12-01
7269097,Exploiting Existing Molecular Scaffolds for Long-TermCOVID Treatment,ACS Medicinal Chemistry Letters,05-27
7241692,Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2,PLoS Pathogens,05-21
7239060,Comparative ACE2 variation and primate COVID-19 risk,bioRxiv,07-21
7161957,The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study,PLoS ONE,04-16
7328171,COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks,Annals of the American Thoracic Society,07-01
7291183,Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials,Journal of Biosciences,06-12
7770470,Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?,Computational and Structural Biotechnology Journal,12-29
7471763,Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease,Medical Hypotheses,09-04
7683280,Emerging diagnostic tools for detection of COVID-19 and perspective,Biomedical Microdevices,11-24
7465781,Emerging Therapeutic Modalities against COVID-19,Pharmaceuticals,08-08
7547839,Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants,Microbes and Infection,10-10
7834737,Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein,Biochimie,11-09
7263495,"A modular framework for multiscale, multicellular, spatiotemporal modeling of acute primary viral infection and immune response in epithelial tissues and its application to drug therapy timing and effectiveness: A multiscale model of viral infection in epithelial tissues",bioRxiv,09-26
7366180,Gene expression and  protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue,The European Respiratory Journal,09-03
7714998,Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections,Frontiers in Molecular Biosciences,11-20
7661960,The flexibility of ACE2 in the context of SARS-CoV-2 infection,Biophysical Journal,11-13
7263493,A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition,bioRxiv,05-20
7431416,An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors,Scientific Reports,08-17
7484587,"Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study",Journal of Biomolecular Structure & Dynamics,08-07
7682384,Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications,Acta Cardiologica,11-19
7302305,Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay,medRxiv,06-02
7773825,"Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be",Frontiers in Molecular Biosciences,12-17
7290204,Coronavirus Disease-19 Has Come Home to Roost in Gastroenterology,Gastroenterology,06-12
7482854,Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19,Human Vaccines & Immunotherapeutics,04-16
7256530,Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of COVID-19 Pandemic,World Neurosurgery,05-29
7237910,Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2,Trends in Microbiology,05-20
7332203,The renin angiotensin aldosterone system and COVID-19,Saudi Pharmaceutical Journal : SPJ,07-02
7490396,Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition,Scientific Reports,09-14
7481766,Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities,Current Hypertension Reports,09-10
7718070,Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification,Journal of Biomedical Research,08-31
7290210,Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein,"Infection, Genetics and Evolution",06-12
7586454,Thermodynamics of the Interaction between the Spike Protein ofSevere Acute Respiratory Syndrome Coronavirus-2 and the Receptor of HumanAngiotensin-Converting Enzyme 2. Effects of PossibleLigands,The Journal of Physical Chemistry Letters,10-21
7831862,The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Physiopathology and Clinical Implications,"Heart, Lung & Circulation",12-09
7194807,"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor",Pharmacological Research,04-14
7605341,Electrochemical SARS-CoV-2 Sensing at Point-of-Care and ArtificialIntelligence for Intelligent COVID-19 Management,ACS Applied Bio Materials,10-27
7544379,Recommendations to Safeguard Reconstructive Microsurgeons Performing High-risk Operations during the COVID-19 Pandemic,Plastic and Reconstructive Surgery Global Open,09-29
7752028,Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2,Journal of Infection and Public Health,12-21
7457611,Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies,bioRxiv,08-30
7330586,Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient,The Journal of Infection,07-02
7471641,SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19,Journal of Hematology & Oncology,09-04
7095063,The proximal origin of SARS-CoV-2,Nature Medicine,03-17
7292051,Does Early Childhood Vaccination Protect Against COVID-19?,Frontiers in Molecular Biosciences,06-05
7737156,A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles,Qrb Discovery,11-17
7757661,A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses,STAR Protocols,12-09
7151394,"COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies",JACC: Basic to Translational Science,04-10
7766484,"Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins",Viruses,12-17
7355571,Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury,Journal of Clinical Medicine,06-03
7610239,Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro,Cell Discovery,11-04
7427697,Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge,Diagnostic Pathology,08-14
7263490,Static All-Atom Energetic Mappings of the SARS-Cov-2 Spike Protein with Potential Latch Identification of the Down State Protomer,bioRxiv,06-10
7673700,Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals,Science Advances,11-06
7235496,"Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures",Reviews in Medical Virology,04-17
7098029,Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2,International Journal of Biological Sciences,03-15
7483033,Antibody-dependent enhancement of coronavirus,International Journal of Infectious Diseases,09-11
7834068,Mathematical model to assess the imposition of lockdown during COVID-19 pandemic,Results in Physics,12-25
7482523,"Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019",Frontiers in Pharmacology,08-27
7231166,"Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19",Journal of Clinical Medicine,04-15
7174861,Understanding the Mosaic of COVID-19: A Review of the Ongoing Crisis,Cureus,03-22
7217142,A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein,bioRxiv,03-17
7370876,COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives,Nature Reviews. Cardiology,07-20
7093072,Emerging Therapeutic Strategies for COVID-19 patients,Discoveries,03-12
7646114,Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies,International Journal of Medical Sciences,10-22
7662033,"Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety",Saudi Pharmaceutical Journal : SPJ,11-13
7337374,Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant,bioRxiv,07-15
7218375,Advances in the relationship between coronavirus infection and cardiovascular diseases,Biomedicine & Pharmacotherapy,05-13
7722825,"Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection",BMJ Open,12-07
7857404,Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate,"Science (New York, N.y.)",10-20
7239077,Site-specific analysis of the SARS-CoV-2 glycan shield,bioRxiv,03-28
7701195,"Designed Metal-ATCUN Derivatives: Redox- and Non-redox-Based Applications Relevant for Chemistry, Biology, and Medicine",iScience,11-10
7156231,Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies,Modern Pathology,04-14
7276046,"Fast spread of COVID-19 in Europe and the US suggests the necessity of early, strong and comprehensive interventions",medRxiv,04-15
7833882,Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy,Advanced Drug Delivery Reviews,12-09
7506191,Integrated genomic view of SARS-CoV-2 in India,Wellcome Open Research,08-03
7260574,Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight,Acta Pharmaceutica Sinica. B,05-30
7336705,Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis,Research Square,06-13
7254035,Resilient and agile engineering solutions to address societal challenges such as coronavirus pandemic,Materials Today. Chemistry,05-28
7476502,Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2,Journal of Pharmaceutical Analysis,09-07
7486399,Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor,Nature Communications,09-11
7331543,Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective,The Journal of Allergy and Clinical Immunology,07-02
7605318,Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT),Emerging Microbes & Infections,11-01
7685703,COVID-19 research risks ignoring important host genes due to pre-established research patterns,eLife,11-24
7574444,Splenic Abscess: An Unusual Presentation of COVID-19?,Dubai Medical Journal,09-07
7205601,An overview of COVID-19,Journal of Zhejiang University. Science. B,05-08
7341421,Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade,Case Reports in Nephrology,06-29
7557167,The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET,"Structure (London, England : 1993)",10-15
7162773,Management and Treatment of COVID-19: The Chinese Experience,The Canadian Journal of Cardiology,04-17
7195984,"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs",Turkish Journal of Medical Sciences,04-21
7435577,Current diagnostic tools for coronaviruses–From laboratory diagnosis to  diagnosis for ‐19,Bioengineering & Translational Medicine,08-13
7681037,Alveolar epithelial cell type II could be the main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: a physio-pathological theory,Medical Hypotheses,11-23
7306405,Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis,Disaster Medicine and Public Health Preparedness,05-18
7494880,Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design,Scientific Data,09-16
7291053,The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor,Viruses,04-30
7295554,COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation,Journal of Clinical Medicine Research,06-04
7551890,"The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection",Nutrients,08-25
7291026,"A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping",Cells,05-20
7571292,Fighting COVID-19 Using Molecular Dynamics Simulations,ACS Central Science,10-12
7523114,A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody,bioRxiv,09-21
7849461,Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease,Vascular Biology,12-11
7430568,An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation,bioRxiv,08-17
7228221,Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2,Journal of Medical Virology,03-11
7708625,"Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir",Scientific Reports,12-01
7557276,One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device,Biosensors & Bioelectronics,10-15
7670890,Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains,Cell Host & Microbe,11-17
7459861,The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting,International Journal of Environmental Research and Public Health,08-05
7388487,Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry,medRxiv,07-19
7645923,"Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis",Cell Proliferation,10-24
7756435,Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike‐ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics,"Chemistry (Weinheim an Der Bergstrasse, Germany)",10-19
7441805,Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformaticsapproach,Journal of Biomolecular Structure & Dynamics,07-17
7586456,Identifying SARS-CoV-2 Entry Inhibitors through Drug RepurposingScreens of SARS-S and MERS-S Pseudotyped Particles,ACS Pharmacology & Translational Science,10-19
7256451,"The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials",Frontiers in Medicine,05-22
7543973,Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools,Informatics in Medicine Unlocked,10-08
7470764,A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors,Cell Reports,09-03
7199731,Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19),Microbial Pathogenesis,05-05
7377724,Sex Differences in Mortality Rates and Underlying Conditions for COVID-19 Deaths in England and Wales,Mayo Clinic Proceedings,07-23
7646041,A Hydrophobic‐Interaction‐Based Mechanism Triggers Docking between the SARS‐CoV‐2 Spike and Angiotensin‐Converting Enzyme 2,Global Challenges,10-15
7448377,Computational Alanine Scanning and Structural Analysis of theSARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2Complex,ACS Nano,08-24
7340062,Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system,Materials Today Physics,07-07
7429092,Analysis of COVID-19 Cases and Public Measures in China,Sn Comprehensive Clinical Medicine,08-15
7657070,"Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates",Journal of Molecular Modeling,11-11
7522255,Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses,NPJ Vaccines,09-28
7361222,An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening,Current Protocols in Microbiology,06-25
7276303,Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity,Cell Reports Medicine,06-08
7799356,Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection,EMBO Molecular Medicine,12-14
7336720,Discovery of Aptamers Targeting the Receptor-Binding Domain of theSARS-CoV-2 Spike Glycoprotein,Analytical Chemistry,06-17
7306100,En route to Peptide Therapeutics for COVID 19: Harnessing Potential Antigenic Mimicry Between Viral and Human Proteins,Transactions of the Indian National Academy of Engineering,06-21
7192093,Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications,Journal of Cardiothoracic and Vascular Anesthesia,04-30
7409833,Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in a Variety of Environmental Conditions,Chem,08-06
7175848,Current status of potential therapeutic candidates for the COVID-19 crisis,"Brain, Behavior, and Immunity",04-22
7337387,Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine,bioRxiv,07-02
7833690,Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine,"Infection, Genetics and Evolution",08-03
7163933,Computational Design of ACE2-Based Peptide Inhibitors ofSARS-CoV-2,ACS Nano,04-14
7228250,Understanding of COVID‐19 based on current evidence,Journal of Medical Virology,03-05
7724979,Theoretical Design of Functionalized Gold Nanoparticles asAntiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2),The Journal of Physical Chemistry Letters,11-23
7300015,Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution,Nature Communications,06-17
7410791,Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach,Genomics,08-07
7418723,A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein,ChemRxiv,08-07
7718587,Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses,Journal of Virological Methods,12-05
7402627,Structural basis of a shared antibody response to SARS-CoV-2,"Science (New York, N.y.)",07-13
7436314,Epigallocatechin gallate and theaflavin gallate interaction in ‐2 spike‐protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study,Drug Development Research,08-07
7737530,Neutralizing antibodies targeting SARS-CoV-2 spike protein,Stem Cell Research,12-15
7591870,"SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases",iScience,10-28
7513813,"ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens",Cell Reports. Medicine,09-24
7511171,Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison,The Lancet. Infectious Diseases,09-23
7834886,Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2,Life Sciences,12-10
7544872,Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method,Scientific Reports,10-08
7386495,Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor,bioRxiv,07-24
7749996,Managing the pandemic from the radiology department’s point of view,Radiologi´a,12-20
7596271,Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease,Frontiers in Pharmacology,10-16
7299140,COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2,Nature Protocols,06-17
7566287,Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke,BMJ Case Reports,10-15
7571304,Falling Dynamics of SARS-CoV-2 as a Function of Respiratory Droplet Size and Human Height,Journal of Medical and Biological Engineering,10-19
7332447,A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition,Cell Host & Microbe,07-03
7327953,"Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions",Experimental Biology and Medicine,04-19
7649697,The Impact of COVID-19 Disease on Platelets and Coagulation,Pathobiology,10-13
7414237,Novel insights on the pulmonary vascular consequences of COVID-19,American Journal of Physiology - Lung Cellular and Molecular Physiology,06-17
7360695,"Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics",Molecular Neurobiology,07-15
7357399,Perspectives for repurposing drugs for the coronavirus disease 2019,The Indian Journal of Medical Research,04-28
7656503,Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection,Cell Research,11-11
7305491,Known drugs and small molecules in the battle for COVID-19 treatment,Genes & Diseases,06-20
7541350,Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation,Nature Structural & Molecular Biology,08-04
7545154,Drug screening and development from the affinity of S protein of new coronavirus with ACE2,European Journal of Clinical Microbiology & Infectious Diseases,10-09
7456831,Bibliometric Analysis on COVID-19: A Comparison of Research Between English and Chinese Studies,Frontiers in Public Health,08-14
7566794,"The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection",JACC: Basic to Translational Science,10-16
7768780,A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine,Proceedings of the National Academy of Sciences of the United States of America,11-30
7746263,SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells,PLoS Pathogens,12-07
7444525,"COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2",PLoS Pathogens,08-21
7248242,COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection,Frontiers in Public Health,05-19
7677074,Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19,The Journal of Allergy and Clinical Immunology,11-20
7467076,Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis,The American Journal of Emergency Medicine,09-02
7831566,Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019,Chinese Journal of Natural Medicines,12-22
7598530,Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells,Cell Reports Medicine,10-29
7473175,SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East,Emerging Microbes & Infections,07-03
7325519,Nanotechnology for COVID-19: Therapeutics and VaccineResearch,ACS Nano,06-22
7498845,"COVID-19 in Human, Animal, and Environment: A Review",Frontiers in Veterinary Science,09-04
7376362,Future antiviral surfaces: Lessons from COVID-19 pandemic,Sustainable Materials and Technologies,07-23
7591232,Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study,"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy",10-23
7462568,Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine,"Infection, Genetics and Evolution",09-01
7383522,Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19,Journal of Clinical Microbiology,07-23
7670824,Epitope-Based Potential Vaccine Candidate for Humoraland Cell-Mediated Immunity to Combat Severe Acute Respiratory SyndromeCoronavirus 2 Pandemic,The Journal of Physical Chemistry Letters,11-11
7247459,"El ambiente, los desplazamientos y el riesgo cardiovascular en la pandemia por COVID-19",Revista Colombiana De Cardiologi´a,05-25
7684150,SARS-CoV-2: a new dimension to our understanding of coronaviruses,International Microbiology,11-24
7452893,A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes,Nature Communications,08-27
7167301,Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19,Military Medical Research,04-20
7752054,A pocket guide on how to structure SARS-CoV-2 drugs and therapies,Biochemical Society Transactions,12-01
7268591,Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study,BMC Medicine,06-03
7463602,Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity,Antioxidants,07-24
7470988,Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19,mSystems,09-01
7505267,Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study,Aging and Disease,10-01
7228330,"A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019‐nCoV)",Journal of Medical Virology,03-29
7695590,One year update on the COVID-19 pandemic: Where are we now?,Acta Tropica,11-28
7299284,Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail,"Science (New York, N.y.)",06-15
7756544,Screening for ‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program,Transfusion,09-16
7474903,Molecular Architecture of the SARS-CoV-2 Virus,Cell,09-06
7251353,Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens,"Infection, Genetics and Evolution",05-27
7490321,Infectivity of SARS-CoV-2: there Is Something More than D614G?,Journal of Neuroimmune Pharmacology,09-15
7802844,A brief outlook on the current emerging trends of COVID 19 vaccines,Journal of Oral and Maxillofacial Pathology : JOMFP,09-09
7480854,Can data from paediatric cohorts solve the COVID-19 puzzle?,PLoS Pathogens,09-09
7406700,Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children,European Journal of Clinical Microbiology & Infectious Diseases,08-06
7227451,Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies,Cellular and Molecular Immunology,05-15
7586785,Conditional cell reprogramming for modeling host‐virus interactions and human viral diseases,Journal of Medical Virology,06-16
7191627,Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility,Physiological Reviews,03-27
7640956,In Silico DrugRepurposing for SARS-CoV-2 MainProteinase and Spike Proteins,Journal of Proteome Research,09-07
7294299,"Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug",Life Sciences,06-15
7584483,An Overview of the Crystallized Structures of the SARS-CoV-2,The Protein Journal,10-24
7337384,Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2,bioRxiv,06-30
7469881,Double-Barreled CRISPR Technology as a Novel TreatmentStrategy For COVID-19,ACS Pharmacology & Translational Science,08-27
7712309,Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation,Vaccines,11-04
7309306,Computational investigation on  phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials,Journal of Biomolecular Structure & Dynamics,06-16
7477656,Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection,World Journal of Stem Cells,08-26
7278991,"COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?",International Journal of Molecular Sciences,05-14
7553147,Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures: SARS-CoV-2 spike prefusion structures,IUCrJ,09-29
7194886,IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study,Clinica Chimica Acta; International Journal of Clinical Chemistry,04-25
7785254,"A modular framework for multiscale, multicellular, spatiotemporal modeling of acute primary viral infection and immune response in epithelial tissues and its application to drug therapy timing and effectiveness",PLoS Computational Biology,12-21
7577279,Translating bioactive peptides for COVID-19 therapy,European Journal of Pharmacology,10-21
7520376,"SARS-CoV-2, an Underestimated Pathogen of the Nervous System",Sn Comprehensive Clinical Medicine,09-28
7665311,In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges,"Science (New York, N.y.)",08-18
7489052,Genomic Cues From Beta-Coronaviruses and Mammalian Hosts Sheds Light on Probable Origins and Infectivity of SARS-CoV-2 Causing COVID-19,Frontiers in Genetics,08-31
7350325,"A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions",Pathogens,05-29
7236801,"Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection",Frontiers in Immunology,05-12
7543084,"Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China",Frontiers in Endocrinology,09-24
7199907,SARS-CoV-2 productively infects human gut enterocytes,"Science (New York, N.y.)",05-01
7144619,Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2,Cell,04-09
7323060,COVID-19: Drug Targets and Potential Treatments,Journal of Medicinal Chemistry,06-08
7264803,Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?,The FASEB Journal,04-19
7380854,A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol,BMJ Open,07-22
7313248,Kann SARS-CoV-2 das Auge infizieren? – Ein Überblick über den Rezeptorstatus in okularem Gewebe,Der Ophthalmologe,06-24
7523238,The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection ina Lateral Flow Point of Care Diagnostic Device,ACS Central Science,09-22
7530945,Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?,Frontiers in Microbiology,09-18
7362842,"Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19",Nitric Oxide,07-15
7190498,The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650,Vaccine,04-30
7126544,The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China,Journal of Autoimmunity,03-03
7327214,Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity,BMC Molecular and Cell Biology,07-01
7582055,Therapeutic Modalities and Novel Approaches in Regenerative Medicine for COVID-19,International Journal of Antimicrobial Agents,10-23
7224694,SARS-CoV-2 (COVID-19) by the numbers,eLife,04-02
7118535,"COVID-19, diabetes mellitus and ACE2: The conundrum",Diabetes Research and Clinical Practice,03-29
7660547,Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking,PLoS ONE,11-12
7779003,"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences",Nucleic Acids Research,11-19
7397953,Cyclosporine: an old weapon in the fight against Coronaviruses,The European Respiratory Journal,11-26
7585498,A safety consideration of mesenchymal stem cell therapy on COVID-19,Stem Cell Research,10-24
7349596,Progress and Prospects on Vaccine Development against SARS-CoV-2,Vaccines,03-29
7203467,Potential SARS-CoV-2 Preimmune IgM Epitopes,Frontiers in Immunology,04-30
7191895,Diagnostic value and key features of computed tomography in Coronavirus Disease 2019,Emerging Microbes & Infections,04-23
7330532,"The COVID-19 pandemic: biological evolution, treatment options and consequences",Innovative Infrastructure Solutions,07-02
7693302,SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity,Nature Communications,11-26
7098069,Broad Spectrum Antiviral Agent Niclosamide and Its TherapeuticPotential,ACS Infectious Diseases,03-03
7242756,Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art,Frontiers in Immunology,05-15
7646037,Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects,Reviews in Medical Virology,10-15
7284245,Current emerging SARS-CoV-2 pandemic: Potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments,Environmental Research,06-10
7596835,SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic,Signal Transduction and Targeted Therapy,10-30
7518233,Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics,International Journal of Antimicrobial Agents,09-25
7251400,Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma,The American Journal of Pathology,05-27
7744885,Pharmacogenomics of genetic polymorphism within the genes responsible for SARS‐CoV‐2 susceptibility and the drug‐metabolising genes used in treatment,Reviews in Medical Virology,11-17
7255993,"Novel corona virus disease (COVID-19) awareness among the dental interns, dental auxiliaries and dental specialists in Saudi Arabia: A nationwide study",Journal of Infection and Public Health,05-29
7450099,SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics,The Journal of Biological Chemistry,06-25
7172573,Angiotensin II for the Treatment of COVID-19–Related Vasodilatory Shock,Anesthesia and Analgesia,03-23
7320995,Hypercytokinemia and Pathogen–Host Interaction in COVID-19,Journal of Inflammation Research,06-23
7303722,Is the kidney a target of SARS-CoV-2?,American Journal of Physiology - Renal Physiology,05-15
7217148,Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2,bioRxiv,03-21
7351676,Long-term infection of SARS-CoV-2 changed the body's immune status,"Clinical Immunology (Orlando, Fla.)",07-11
7676267,Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19,Scientific Reports,11-18
7541824,"Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severity",Clinical & Translational Immunology,10-07
7498231,Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions,Trends in Immunology,09-17
7317266,The global emergence of severe acute respiratory syndrome coronavirus 2 in human,VirusDisease,06-26
7643658,"The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design",Biochemical and Biophysical Research Communications,11-05
7554608,Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age,Frontiers in Physiology,09-30
7337377,High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity,bioRxiv,07-01
7724658,"Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms",bioRxiv,12-02
7553162,Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3--sulfated heparan sulfate,bioRxiv,10-08
7770894,ANanomechanical Study on Deciphering the Stickiness of SARS-CoV-2 on Inanimate Surfaces,ACS Applied Materials & Interfaces,12-18
7651197,Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain–human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2,Journal of Biomolecular Structure & Dynamics,11-04
7306998,COVID-19-associated coagulopathy: An exploration ofmechanisms,"Vascular Medicine (London, England)",06-19
7221370,"Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism",Biochemical and Biophysical Research Communications,05-14
7239051,The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2,bioRxiv,05-11
7472384,Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?,Viruses,08-07
7472982,An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates,Heliyon,09-04
7328981,Structural basis of receptor recognition by SARS-CoV-2,Nature,03-30
7188049,Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2,Circulation Research,04-23
7430299,Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions,Immunity,08-17
7268261,Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy,Bioscience Reports,06-02
7093988,Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus,Infectious Diseases of Poverty,03-25
7345039,Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population,International Journal of Environmental Research and Public Health,06-15
7437850,Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis,Medicine,08-14
7403965,A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0,International Journal of Molecular Sciences,07-21
7354745,Changes of hematological and immunological parameters in COVID-19 patients,International Journal of Hematology,07-12
7414823,Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19,Anatolian Journal of Cardiology,07-03
7518726,COVID-19 and the Heart,Colombia Médica : CM,06-30
7543285,Origin-independent analysis links SARS-CoV-2 local genomes with COVID-19 incidence and mortality,Briefings in Bioinformatics,09-14
7276034,Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19,medRxiv,04-22
7718591,Chasing COVID-19 through SARS-CoV-2 spike glycoprotein,VirusDisease,12-05
7701095,How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis,Frontiers in Psychiatry,11-16
7352498,Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses,Nanomaterials,05-31
7605336,Targeting Crucial Host Factors of SARS-CoV-2,ACS Infectious Diseases,10-28
7597426,Profile of SARS-CoV-2,Wiener Klinische Wochenschrift,10-30
7239005,Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution,Gene,05-20
7437481,A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2,Cell,08-19
7534663,Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein,Journal of Structural Biology: X,10-05
7187729,Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis,Research,04-19
7198407,"COVID-19, SARS and MERS: A neurological perspective",Journal of Clinical Neuroscience,05-05
7314503,SARS-CoV-2 neutralizing antibody development strategies,Turkish Journal of Biology,06-21
7567416,"SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations",VirusDisease,10-16
7728258,CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention,PLoS ONE,12-10
7191060,COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?,Frontiers in Cardiovascular Medicine,04-23
7279633,Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment,Internal and Emergency Medicine,06-08
7543703,Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection,Virus Research,10-08
7409919,Structure of Furin Protease Binding to SARS-CoV-2 SpikeGlycoprotein and Implications for Potential Targets andVirulence,The Journal of Physical Chemistry Letters,07-28
7293183,"Growth, detection, quantification, and inactivation of SARS-CoV-2",Virology,06-13
7765775,Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19,Cell Communication and Signaling : CCS,12-27
7744274,Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition,Journal of Molecular Biology,12-17
7222554,"COVID-19 pandemic: an overview of epidemiology, parthenogenesis, diagnostics and potential vaccines and therapeutics",Therapeutic Delivery,05-13
7808873,Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19,Genomics & Informatics,12-07
7251277,The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey,Northern Clinics of Istanbul,05-15
7303337,New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection,Frontiers in Pharmacology,06-12
7195011,ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia,Autoimmunity Reviews,04-03
7522990,Structural and functional modelling of SARS-CoV-2 entry in animal models,Scientific Reports,09-28
7771898,Mucin signature as a potential tool to predict susceptibility to COVID‐19,Physiological Reports,12-29
7781310,An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants,bioRxiv,12-21
7355337,Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients,Cell,07-13
7643666,New putative animal reservoirs of SARS-CoV-2 in Italian fauna: A bioinformatic approach,Heliyon,11-05
7574780,"COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome",Journal of Infection and Public Health,10-20
7187825,Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein,International Journal of Antimicrobial Agents,04-28
7395940,Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2,Infectious Diseases of Poverty,07-10
7426442,Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past,Frontiers in Immunology,08-07
7723706,Suspected SARS-CoV-2 infection with fever and coronary heart disease: A case report,World Journal of Clinical Cases,12-06
7480895,"COVID-19: Current status, Challenges and Future Perspectives",Indian Journal of Clinical Biochemistry,09-09
7350231,SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries,Vaccines,06-23
7439967,"Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies",Heliyon,08-20
7591868,Transforming vaccine development,Seminars in Immunology,10-28
7315394,"Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community",Research,06-16
7720734,"Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells",Journal of Biotechnology,12-07
7724996,"COVID-19: An Update on the Epidemiological, Clinical, Preventive, and Therapeutic Management of 2019 Novel Coronavirus Disease",Critical Care Nursing Quarterly,12-01
7501778,Thermodynamic equilibrium dose-response models for MERS-CoV infection reveal a potential protective role of human lung mucus but not for SARS-CoV-2,Microbial Risk Analysis,09-19
7402631,Structure-based design of prefusion-stabilized SARS-CoV-2 spikes,"Science (New York, N.y.)",07-23
7283733,"Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control",Electrophoresis,06-08
7163230,Does the direct renin inhibitor have a role to play in attenuatingseverity of the outbreak coronavirus disease 2019 (COVID-19)?,Therapeutic Advances in Endocrinology and Metabolism,04-16
7703223,SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy,Asian Journal of Urology,11-30
7466534,The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development,Frontiers in Immunology,08-19
7402622,Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody,"Science (New York, N.y.)",07-23
7591918,Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation,Nature Communications,10-27
7263255,"Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements",Life Sciences,06-01
7284144,Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study,Journal of Biomolecular Structure & Dynamics,06-01
7465881,Neurological injuries in COVID-19 patients: direct viral invasion or a  injury after infection of epithelial/endothelial cells,Journal of Neurovirology,09-02
7484581,"Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants –  (Ashwagandha),  (Giloy) and  (Tulsi) – a molecular docking study",Journal of Biomolecular Structure & Dynamics,08-27
7554878,"The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection",Antioxidants,08-25
7307820,Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review),International Journal of Molecular Medicine,05-18
7640888,Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.,Cell,11-04
7705736,Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform,Nature Communications,11-30
7762362,Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules,Pharmaceuticals,12-08
7500119,COVID-19 and Tuberculosis,Journal of Translational Internal Medicine,06-25
7343218,"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity",Journal of Virology,07-01
7432271,COVID-19: The Immune Responses and Clinical Therapy Candidates,International Journal of Molecular Sciences,08-03
7337391,Using iCn3D and the World Wide Web for structure-based collaborative research: Analyzing molecular interactions at the root of COVID-19,bioRxiv,07-06
7359518,A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone,bioRxiv,08-22
7434367,Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents,International Journal of Hygiene and Environmental Health,08-18
7202815,Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community,World Neurosurgery,05-06
7663346,"Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies",Molecules,10-29
7767094,Virus-Mediated Cell-Cell Fusion,International Journal of Molecular Sciences,12-17
7405774,Melatonin potentials against viral infections including COVID-19: Current evidence and new findings,Virus Research,08-05
7571477,Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses,Neuroscience and Biobehavioral Reviews,10-19
7518242,Sustainable Personal Protective Clothing for Healthcare Applications: AReview,ACS Nano,08-31
7605339,Roadmap to the Bioanalytical Testing of COVID-19: From SampleCollection to Disease Surveillance,ACS Sensors,10-30
7277631,Optimizing Anti-Viral Vaccine Responses: Input from a Non-Specialist,Antibiotics,05-15
7574689,High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States,Cell Reports,10-20
7572001,Differences and prediction of imaging characteristics of COVID-19 and non-COVID-19 viral pneumonia: A multicenter study,Medicine,10-16
7205616,Diabetes and metabolic syndrome as risk factors for COVID-19,Diabetes & Metabolic Syndrome,05-08
7729279,Recent updates on COVID-19: A holistic review,Heliyon,12-11
7541099,Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications,Inflammation,10-08
7836940,"2020 update on human coronaviruses: One health, one world",Medicine in Novel Technology and Devices,08-29
7238751,Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections,Future Virology,05-20
7263518,Developing a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein Model in a Viral Membrane,bioRxiv,06-17
7289749,Fight against novel coronavirus: A perspective of medicinal chemists,European Journal of Medicinal Chemistry,06-12
7239062,A serological assay to detect SARS-CoV-2 seroconversion in humans,medRxiv,04-16
7272717,Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation,Frontiers in Immunology,05-29
7605138,COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms,Signal Transduction and Targeted Therapy,11-02
7687297,SSSCPreds: Deep Neural Network-Based Software forthe Prediction of Conformational Variability and Application to SARS-CoV-2,ACS Omega,11-19
7414363,Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments,International Immunopharmacology,08-08
7276302,Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients,Cell Reports Medicine,06-08
7816429,COVID-19 endocrinopathy with hindsight from SARS,American Journal of Physiology - Endocrinology and Metabolism,11-25
7556165,ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives,Frontiers in Molecular Biosciences,09-30
7705443,Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection,Cell Research,12-01
7558349,SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence,Pathogens,08-20
7474329,How can nanotechnology help to combat COVID-19? Opportunities and urgent need,Journal of Nanobiotechnology,09-05
7334944,Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus,European Journal of Pharmacology,07-04
7252579,Controlling the SARS-CoV-2 Spike Glycoprotein Conformation,bioRxiv,05-18
7711728,Association between cardiac troponin I and mortality in patients with COVID-19,Biomarkers,11-24
7416604,A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment,Frontiers in Molecular Biosciences,08-03
7645072,Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain,Frontiers in Chemistry,10-23
7493723,"Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)",Future Microbiology,08-27
7286221,COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection,Journal of Translational Medicine,06-10
7764432,Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction,Molecules,12-13
7442812,A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction,Nature Communications,08-21
7490329,Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses,Frontiers in Molecular Biosciences,09-01
7761982,FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2,Pharmaceuticals,12-04
7073332,Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2,Cell Discovery,03-16
7205603,A Precision Medicine Approach to SARS-CoV-2 Pandemic Management,Current Treatment Options in Allergy,05-08
7219860,Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19),Journal of Cardiovascular Pharmacology,04-02
7256348,Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary,Journal of Biomolecular Structure & Dynamics,05-20
7642307,"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","Clinical Science (London, England : 1979)",11-04
7362808,Coagulopathy in COVID-19: Focus on vascular thrombotic events,Journal of Molecular and Cellular Cardiology,07-15
7104723,Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion,Cell Research,03-30
7282741,"Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9",iScience,06-09
7564417,"Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development",Vaccines,07-20
7784839,Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity,Journal of Biomolecular Structure & Dynamics,12-17
7728342,In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2,Molecules,11-25
7394063,"Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach",PeerJ,07-27
7522650,An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain,Cell Reports,09-29
7335243,"Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development",Asian Journal of Pharmaceutical Sciences,07-04
7554297,Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs,Computers in Biology and Medicine,10-14
7490508,"Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity",Obesity Facts,08-13
7332453,Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2,Cell Host & Microbe,07-03
7438995,Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review,BJA: British Journal of Anaesthesia,08-20
7267122,Three months of ‐19: A systematic review and meta‐analysis,Reviews in Medical Virology,05-18
7286219,mRNA Vaccines: Possible Tools to Combat SARS-CoV-2,Virologica Sinica,06-10
7544689,"SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden",Nature Communications,10-08
7098031,Zoonotic origins of human coronaviruses,International Journal of Biological Sciences,03-15
7762830,Comparison of spatio-temporal transmission characteristics of COVID-19 and its mitigation strategies in China and the US,Journal of Geographical Sciences,12-26
7705847,Thrombocytopenia and thrombosis in hospitalized patients with COVID-19,Journal of Hematology & Oncology,12-01
7387805,SARS-CoV-2: characteristics and current advances in research,Virology Journal,07-29
7219429,Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal,International Journal of Antimicrobial Agents,05-13
7442131,From SARS to COVID-19: What lessons have we learned?,Journal of Infection and Public Health,08-21
7323606,Drug targets for COVID-19 therapeutics: Ongoing global efforts,Journal of Biosciences,06-29
7364852,Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics,Future Medicinal Chemistry,07-16
7594996,IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19,Molecular Medicine,10-29
7286275,Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery,Hellenic Journal of Cardiology,06-10
7834635,Understanding the Structure and Function of Viral Glycosylation by Molecular Simulations: State-of-the-Art and Recent Case Studies,"Reference Module in Chemistry, Molecular Sciences and Chemical Engineering",12-21
7341691,Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model ina Viral Membrane,The Journal of Physical Chemistry. B,06-19
7762703,D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction,Cell Reports,12-26
7773544,Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering,Computational and Structural Biotechnology Journal,12-31
7491521,Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition,bioRxiv,09-28
7857400,Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2,"Science (New York, N.y.)",11-05
7346785,Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks,Cell,07-09
7397991,Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review,Life Sciences,08-03
7359526,Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures,bioRxiv,07-08
7262057,Evaluate severe acute respiratory syndrome coronavirus 2 infectivity by pseudoviral particles,Journal of Medical Virology,04-25
7324114,Docking approaches for modeling multi-molecular assemblies,Current Opinion in Structural Biology,06-29
7223722,A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2,"Science (New York, N.y.)",05-13
7354743,SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus,Inflammation Research,07-12
7665507,Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases,Inflammatory Bowel Diseases,10-22
7265857,"Assessing the relationship between surface levels of PM2.5 and PM10 particulate matter impact on COVID-19 in Milan, Italy",The Science of the Total Environment,06-02
7448950,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Trends in Genetics,08-26
7418715,Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate,bioRxiv,08-06
7211627,A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein,Current Biology,05-11
7261327,Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?,BioMed Research International,05-30
7259789,Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-19,PLoS ONE,05-29
7437106,Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?,BMC Medicine,08-19
7387874,COVID-19: A Concern for Cardiovascular Disease Patients,Cardiovascular Toxicology,07-29
7409838,The development of Coronavirus 3C-Like protease (3CL) inhibitors from 2010 to 2020,European Journal of Medicinal Chemistry,08-06
7201239,"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","Journal of Microbiology, Immunology, and Infection",05-06
7529405,Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis,"Lancet (London, England)",10-01
7297697,Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine,Journal of Molecular Liquids,06-17
7247522,COVID-19 created chaos across the globe: Three novel quarantine epidemic models,"Chaos, Solitons, and Fractals",05-25
7291920,Perspectives on the development of neutralizing antibodies against SARS-CoV-2,Antibody Therapeutics,05-20
7581292,Chemosensory Dysfunction in COVID-19: Integrationof Genetic and Epidemiological Data Points to D614G Spike ProteinVariant as a Contributing Factor,ACS Chemical Neuroscience,09-30
7560266,A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2),Biosensors & Bioelectronics,10-15
7435514,"Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor",Journal of Biochemical and Molecular Toxicology,08-08
7534785,Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review,"Journal of Microbiology, Immunology, and Infection",10-05
7400297,Molecular Aspects of COVID-19 Differential Pathogenesis,Pathogens,07-06
7157541,SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far,Pathogens,03-20
7331933,The Discovery of a Putative Allosteric Site in the SARS-CoV-2Spike Protein Using an Integrated Structural/DynamicApproach,Journal of Proteome Research,06-17
7491508,Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro,bioRxiv,09-09
7197630,SARS-CoV-2 can induce brain and spine demyelinating lesions,Acta Neurochirurgica,05-04
7323663,Minireview of progress in the structural study of SARS-CoV-2 proteins,Current Research in Microbial Sciences,06-29
7557250,Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples,Signal Transduction and Targeted Therapy,10-15
7361198,Angiotensin‐converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection,Reviews in Medical Virology,06-30
7670907,COVID-19: A review of therapeutic strategies and vaccine candidates,"Clinical Immunology (Orlando, Fla.)",11-17
7314898,ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?,Frontiers in Medicine,06-18
7365854,Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report,Frontiers in Cell and Developmental Biology,07-10
7102632,SARS Coronavirus Redux,Trends in Immunology,03-12
7417784,Advances in research on ACE2 as a receptor for 2019-nCoV,Cellular and Molecular Life Sciences,08-11
7646264,Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases,Clinical and Experimental Allergy,10-06
7834510,"History of the COVID-19 pandemic: Origin, explosion, worldwide spreading",Biochemical and Biophysical Research Communications,11-06
7396720,Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19,Acta Pharmacologica Sinica,08-03
7162778,Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019,Cardiovascular Pathology,04-17
7197033,Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain,Frontiers of Medicine,05-04
7162643,COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities,JACC: Basic to Translational Science,04-16
7537586,Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system,Herz,10-06
7720688,Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19,ERJ Open Research,12-07
7215413,COVID-19 Drug Discovery Using Intensive Approaches,International Journal of Molecular Sciences,04-18
7324922,"Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission","Infection, Genetics and Evolution",06-30
7235495,"COVID‐19: Risk groups, mechanistic insights and challenges",International Journal of Clinical Practice,05-12
7717483,Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2,Access Microbiology,09-08
7315836,Inhibitors of SARS-CoV-2 Entry: Current and FutureOpportunities,Journal of Medicinal Chemistry,06-15
7194821,A Genomic Perspective on the Origin and Emergence of SARS-CoV-2,Cell,03-26
7273044,A global treatments for coronaviruses including COVID‐19,Journal of Cellular Physiology,05-11
7749647,DNA vaccines against COVID-19: Perspectives and challenges,Life Sciences,12-19
7317023,A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic,Frontiers in Pharmacology,06-19
7604128,Human coronavirus spike protein-host receptor recognition,Progress in Biophysics and Molecular Biology,10-31
7756008,Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020),Frontiers in Immunology,12-09
7459237,Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis,Infection and Drug Resistance,08-25
7438372,Emerging strategies on  drug development against COVID-19: challenges and opportunities,European Journal of Pharmaceutical Sciences,08-20
7404951,", a knowledge‐mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via",Drug Development Research,07-13
7302216,Closing coronavirus spike glycoproteins by structure-guided design,bioRxiv,06-03
7194930,Blockade of SARS-CoV-2 infection by recombinant soluble ACE2,Kidney International,04-14
7535797,Research Progress of Nucleic Acid Detection Technology Platforms for New Coronavirus SARS-CoV-2,Chinese Journal of Analytical Chemistry,10-05
7151354,A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2,The Journal of Infection,04-10
7723437,Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments,Frontiers in Pharmacology,10-29
7203508,Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy,Frontiers in Cardiovascular Medicine,04-30
7256127,Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?,British Journal of Clinical Pharmacology,05-13
7577273,A multiple therapy hypothesis for treatment of COVID-19 patients,Medical Hypotheses,10-21
7523740,The Role of Sex in the Risk of Mortality From COVID-19 Amongst Adult Patients: A Systematic Review,Cureus,08-29
7425796,Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes,Genome Medicine,08-13
7363382,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities","Shock (Augusta, Ga.)",05-18
7247487,computational screening of  - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein,Journal of Ayurveda and Integrative Medicine,05-25
7749995,Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2,Journal of Controlled Release,12-20
7118633,Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV,International Journal of Infectious Diseases,04-01
7183246,"Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019",Journal of Global Health,04-24
7568482,The roles of nausea and vomiting in COVID-19: did we miss something?,"Journal of Microbiology, Immunology, and Infection",10-17
7533202,"Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence",Infection & Chemotherapy,09-16
7244094,The hallmarks of COVID-19 disease,PLoS Pathogens,05-22
7556779,Mechanisms of SARS-CoV-2 Transmission and Pathogenesis,Trends in Immunology,10-14
7448286,The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients,Journal of the Endocrine Society,07-28
7205703,Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE),Journal of Stroke and Cerebrovascular Diseases,05-08
7141517,Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19),Journal of Clinical Medicine,03-20
7675878,COVID-19 and the pulmonary vascular injury,Journal of the Renin-Angiotensin-Aldosterone System: JRAAS,11-12
7450963,The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789,BMC Research Notes,08-27
7460647,Deciphering SARS-CoV-2 Virologic and Immunologic Features,International Journal of Molecular Sciences,08-18
7748971,Unraveling the Origin of Interactions of Hydroxychloroquine with the Receptor-Binding Domain of SARS-CoV-2 in Aqueous Medium,Chemical Physics Letters,12-19
7263487,Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein,bioRxiv,06-08
7651184,Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?,Autophagy,11-05
7682957,Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2,Gastroenterology and Hepatology From Bed to Bench,09-20
7102615,One size does not fit all – Patterns of vulnerability and resilience in the COVID-19 pandemic and why heterogeneity of disease matters,"Brain, Behavior, and Immunity",03-20
7437504,The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19,Frontiers in Immunology,08-11
7193113,"The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses",Frontiers in Microbiology,04-24
7646058,A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2,EMBO Molecular Medicine,11-03
7685130,Structural insights into SARS-CoV-2 proteins,Journal of Molecular Biology,11-24
7640965,Targeting Proteasesfor Treating COVID-19,Journal of Proteome Research,10-22
7444473,Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2,"Infection, Genetics and Evolution",08-24
7836795,Dynamic anti-spike protein antibody profiles in COVID-19 patients,International Journal of Infectious Diseases,12-10
7337389,Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation,bioRxiv,06-30
7483483,Analysis of  genetic variants in 131 Italian SARS-CoV-2-positive patients,Human Genomics,09-11
7381402,Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges,iScience,07-25
7374936,Considerations around the SARS-CoV-2 Spike Protein with Particular Attentionto COVID-19 Brain Infection and Neurological Symptoms,ACS Chemical Neuroscience,07-06
7250787,Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19,Cell,05-27
7547605,Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19,Biochemical and Biophysical Research Communications,10-10
7205718,Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking,International Journal of Antimicrobial Agents,05-08
7493775,The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2,Journal of the Chinese Medical Association,05-20
7488724,No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19,Nanomedicine,09-02
7228340,Coronavirus disease 2019: What we know?,Journal of Medical Virology,03-28
7287953,Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming,Molecules,05-22
7483052,Single-cell transcriptomic atlas of primate cardiopulmonary aging,Cell Research,09-10
7794844,Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology,Molecules,12-24
7585068,Neurological manifestations in COVID-19 and its possible mechanism,Aging (Albany NY),09-27
7445466,"SARS-CoV-2 another kind of liver aggressor, how does it do that?",Annals of Hepatology,08-25
7362859,Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach,International Journal of Biological Macromolecules,07-15
7518058,SARS-CoV-2 (COVID-19) and cystic fibrosis,American Journal of Physiology - Lung Cellular and Molecular Physiology,07-15
7834116,Gestión de la pandemia. Visión del radiólogo,Radiologia,11-16
7157630,Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks,Pathogens,03-04
7737509,Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2,Journal of Infection and Public Health,12-15
7531286,Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2,Phytomedicine,10-02
7501082,Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches,Biochemical Pharmacology,09-19
7560643,Assessing the consequences of environmental exposures on the expression of the human receptor and proteases involved in SARS-CoV-2 cell-entry,Environmental Research,10-15
7282763,Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis,Medical Hypotheses,06-09
7695975,A Multiscale Coarse-Grained Model of the SARS-CoV-2 Virion,Biophysical Journal,11-28
7662682,"Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via  Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations",Frontiers in Chemistry,10-30
7286911,Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2,Nature Communications,06-10
7730435,Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry,Scientific Reports,12-10
7457863,A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment,Biologics : Targets & Therapy,08-25
7857415,Enhanced SARS-CoV-2 neutralization by dimeric IgA,Science Translational Medicine,12-07
7191300,Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment,International Journal of Antimicrobial Agents,04-30
7182753,COVID-19 pandemic—a focused review for clinicians,Clinical Microbiology and Infection,04-25
7717879,Micronutrients and Bioactive Substances: Their Potential Roles in Combating COVID-19,"Nutrition (Burbank, Los Angeles County, Calif.)",12-04
7310662,Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection,medRxiv,06-18
7228703,On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2,Virus Research,05-15
7460888,SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells,International Journal of Molecular Sciences,08-09
7094090,Research and Development on Therapeutic Agents and Vaccines for COVID-19and Related Human Coronavirus Diseases,ACS Central Science,03-12
7377983,"The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future",Life Sciences,07-24
7276322,Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation,Immunity,06-08
7422836,Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses,Asian Journal of Psychiatry,08-12
7154215,The epidemiology and clinical information about COVID-19,European Journal of Clinical Microbiology & Infectious Diseases,04-14
7243778,Coronaviruses pandemics: Can neutralizing antibodies help?,Life Sciences,05-22
7194125,Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control,Frontiers in Immunology,04-24
7576208,Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2,Scientific Reports,10-20
7642358,"Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2",Nature Communications,11-04
7753379,Why are  binding coronavirus strains /‐2 wild and  mild?,Proteins,11-27
7227161,Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management,Journal of Translational Internal Medicine,05-09
7662254,"COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies",International Journal of Environmental Research and Public Health,11-04
7228740,COVID-19: CADD to the rescue,Virus Research,05-15
7506210,Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2,Signal Transduction and Targeted Therapy,09-22
7198232,Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients,eLife,04-06
7302197,Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein,bioRxiv,09-04
7586457,Comprehensive Analysis of the Glycan Complement of SARS-CoV-2Spike Proteins Using Signature Ions-TriggeredElectron-Transfer/Higher-Energy Collisional Dissociation (EThcD) MassSpectrometry,Analytical Chemistry,10-16
7537541,"COVID‐19, nausea, and vomiting",Journal of Gastroenterology and Hepatology,10-05
7414299,Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning,Clinics in Laboratory Medicine,08-08
7367032,Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis,Cell Metabolism,07-17
7831793,Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity,International Immunopharmacology,12-16
7309303,An  approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease,Journal of Biomolecular Structure & Dynamics,06-16
7357286,The renin–angiotensin–aldosterone system: Role in pathogenesis and potential therapeutic target in COVID‐19,Pharmacology Research & Perspectives,07-13
7537523,‐2 (‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments,Cell Biochemistry and Function,09-29
7300451,"Dengue Fever, ‐19 (‐2), and  Enhancement (): A Perspective",Cytometry,06-07
7552617,(SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas),Animals : an Open Access Journal from MDPI,08-20
7593407,Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike,Frontiers in Neurology,10-15
7422860,In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension,The Journal of Infection,08-12
7565143,Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?,Biomolecules,09-11
7314447,Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium,JACC: Basic to Translational Science,06-24
7236734,Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019,Chronic Diseases and Translational Medicine,05-19
7644209,Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),Human Vaccines & Immunotherapeutics,09-22
7315997,Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes,bioRxiv,06-23
7414236,Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury,American Journal of Physiology - Lung Cellular and Molecular Physiology,07-08
7340259,COVID-19 and cryo-EM,IUCrJ,07-02
7527407,"Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution",Frontiers in Microbiology,09-17
7680063,3D culture models to study SARS-CoV-2 infectivity and antiviral candidates: From spheroids to bioprinting,Biomedical Journal,11-21
7247499,Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2,Archives of Medical Research,05-25
7476961,Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19,Bioorganic Chemistry,09-08
7724683,"Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC",medRxiv,12-04
7488894,A quick look at the latest developments in the COVID-19 pandemic,The Journal of International Medical Research,09-10
7404672,Clusters of 2019 coronavirus disease (COVID‐19) cases in Chinese tour groups,Transboundary and Emerging Diseases,07-27
7574255,A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity,medRxiv,10-16
7443512,Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission,"Clinical Science (London, England : 1979)",08-21
7373127,Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs,bioRxiv,09-18
7367865,Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein,Nature Communications,07-17
7255728,Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site,iScience,05-28
7572790,Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2,Trends in Pharmacological Sciences,07-31
7430613,"Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure",medRxiv,08-15
7533045,COVID-19 and multiorgan failure: A narrative review on potential mechanisms,Journal of Molecular Histology,10-04
7194065,A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells,Molecular Cell,05-01
7477106,Drug Weaponry to Fight Against SARS-CoV-2,Frontiers in Molecular Biosciences,08-25
7105968,Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection,Virologica Sinica,03-31
7743070,The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike,bioRxiv,12-09
7311167,Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization,eLife,06-23
7375973,Mutations Strengthened SARS-CoV-2 Infectivity,Journal of Molecular Biology,07-23
7654774,Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of “Up” versus “Down” protomer states,PLoS ONE,11-10
7499575,"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview",Pathogens and Disease,08-25
7685318,An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines,bioRxiv,11-18
7557813,Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization,Membranes,08-30
7604074,Functional and druggability analysis of the SARS-CoV-2 proteome,European Journal of Pharmacology,11-01
7392886,The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach,Life Sciences,07-31
7202902,Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?,Clinical Hypertension,05-07
7657873,Mutations in the SARS-CoV-2 Spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization,Computational and Structural Biotechnology Journal,11-12
7744810,Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2,Frontiers in Medicine,12-03
7464909,Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer,Cancers,08-18
7438449,Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19,Frontiers in Medicine,08-13
7537056,COVID‐19 and seizures: Is there a link?,Epilepsia,09-17
7534290,Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody test,Infection Ecology & Epidemiology,09-20
7709177,A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry,bioRxiv,11-24
7505600,Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction,Heliyon,09-21
7418564,SARS-CoV-2-Encoded Proteome and Human Genetics: FromInteraction-Based to Ribosomal Biology Impact on Disease and RiskProcesses,Journal of Proteome Research,07-20
7596956,A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets,Journal of Biomolecular Structure & Dynamics,10-19
7145538,"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes",GeroScience,04-10
7836435,"Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19",Genes & Diseases,09-05
7585069,"SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime",Aging (Albany NY),09-29
7094171,"Evidence of the COVID-19 Virus Targeting the CNS:Tissue Distribution, Host–Virus Interaction, and Proposed NeurotropicMechanisms",ACS Chemical Neuroscience,03-13
7427122,Dynamic Asymmetry Exposes 2019-nCoV PrefusionSpike,The Journal of Physical Chemistry Letters,08-03
7430571,Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2,bioRxiv,08-12
7799268,The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies,Briefings in Bioinformatics,12-22
7348784,Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19,Cells,06-02
7711739,Recombinant vaccines for COVID-19,Human Vaccines & Immunotherapeutics,11-24
7189847,Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering,Progress in Biophysics and Molecular Biology,04-29
7264561,Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics,Chemmedchem,05-07
7396417,Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2,Frontiers in Cellular and Infection Microbiology,07-27
7118423,"Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment",International Journal of Antimicrobial Agents,03-29
7371935,"Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan",Frontiers in Endocrinology,07-14
7664360,Functional importance of the D614G mutation in the SARS-CoV-2 spike protein,Biochemical and Biophysical Research Communications,11-13
7563913,COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein,Biology Direct,10-16
7474075,Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease,Nature Communications,09-04
7803552,Influence of aging on deterioration of patients with COVID-19,Aging (Albany NY),11-24
7221011,Pathophysiology of COVID-19: Why Children Fare Better than Adults?,Indian Journal of Pediatrics,05-14
7491317,The Answer Lies in the Energy: How Simple Atomistic MolecularDynamics Simulations May Hold the Key to Epitope Prediction on the FullyGlycosylated SARS-CoV-2 Spike Protein,The Journal of Physical Chemistry Letters,09-04
7138178,"The epidemiology, diagnosis and treatment of COVID-19",International Journal of Antimicrobial Agents,03-28
7656886,Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis,BMJ Open,11-10
7319648,Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach,International Journal of Biological Macromolecules,06-26
7534308,SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease,Emerging Microbes & Infections,09-25
7709164,A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions,Research Square,11-24
7754931,Cordycepin: a bioactive metabolite of C and polyadenylation inhibitor with therapeutic potential against COVID-19,Journal of Biomolecular Structure & Dynamics,11-23
7567490,"Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model",Journal of Molecular Graphics & Modelling,10-16
7444305,SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness,medRxiv,08-17
7763676,"Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2",Cells,12-08
7270578,Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?,Archives of Medical Research,03-27
7280142,COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer,European Urology Focus,06-09
7422796,"Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites",Drug Discovery Today,08-12
7228390,The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID‐19): A Chinese perspective,Journal of Medical Virology,03-12
7431661,Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review,Frontiers in Cardiovascular Medicine,08-11
7269898,COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice,Human Genomics,06-04
7172500,Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in HumanNasopharyngeal Swab Specimens Using Field-Effect Transistor-BasedBiosensor,ACS Nano,04-15
7723891,"SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development",Frontiers in Cellular and Infection Microbiology,11-25
7745468,Clinical features and radiological manifestations of COVID-19 disease,World Journal of Radiology,11-28
7156795,Toward understanding the 2019 Coronavirus and its impact on the heart,Journal of Thrombosis and Thrombolysis,04-15
7407364,Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications,Pharmaceuticals,07-18
7753514,May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?,Journal of Translational Medicine,12-22
7252096,SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues,Cell,04-27
7264656,Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months,Journal of Cellular and Molecular Medicine,05-07
7571139,Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction,Molecules,09-10
7486595,Making Waves Perspectives of Modelling and Monitoring of SARS-CoV-2 in Aquatic Environment for COVID-19 Pandemic,Current Pollution Reports,09-12
7753416,Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?,Journal of Neuroscience Research,11-20
7675406,Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19,Nature Reviews. Immunology,11-19
7481764,"Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa",Nature Reviews. Microbiology,09-10
7253482,Vulnerabilities in coronavirus glycan shields despite extensive glycosylation,Nature Communications,05-27
7494283,Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology,Cell,09-16
7257377,Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review,Frontiers in Neurology,05-22
7416180,SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19),Bosnian Journal of Basic Medical Sciences,08-01
7400328,"SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings",Pathogens,07-07
7423575,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives,"Brain, Behavior, & Immunity - Health",08-13
7250743,COVID-19 : physiopathologie d’une maladie à plusieurs visages,La Revue De Medecine Interne,05-27
7313936,Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019,The Journal of Infectious Diseases,05-19
7716628,Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study,In Silico Pharmacology,12-04
7356137,Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19,Critical Care,07-13
7063555,The third coronavirus epidemic in the third millennium: what’s next?,Croatian Medical Journal,02-01
7545713,"Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)",International Journal of Biological Sciences,09-12
7598563,Is highly expressed ACE 2 in pregnant women “a curse” in times of COVID-19 pandemic?,Life Sciences,10-28
7452956,"Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike",Computational and Structural Biotechnology Journal,07-31
7466921,Impact of glycemic control in diabetes mellitus on management of COVID-19 infection,International Journal of Diabetes in Developing Countries,09-02
7664471,Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles,Cell Host & Microbe,11-13
7843151,Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics,International Immunopharmacology,09-08
7668741,A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening,ChemRxiv,07-24
7278654,Computational modelling of flavivirus dynamics: The ins and outs,"Methods (San Diego, Calif.)",06-08
7663203,SARS-CoV-2/Renin–Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle,International Journal of Molecular Sciences,10-24
7577845,COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms,Sn Comprehensive Clinical Medicine,10-22
7282679,Update on the target structures of SARS-CoV-2: A systematic review,Indian Journal of Pharmacology,06-03
7738279,Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome,Computational and Structural Biotechnology Journal,12-16
7571527,Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease,Molecular Neurobiology,10-19
7601131,"Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations",Pharmaceuticals,09-28
7199903,Site-specific glycan analysis of the SARS-CoV-2 spike,"Science (New York, N.y.)",05-04
7592233,SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig,Journal of Virology,10-27
7505773,"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2",Biochimie,09-22
7573309,Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19,Frontiers in Cell and Developmental Biology,10-06
7423517,How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing,Talanta,08-13
7386394,"COVID-19 and SARS-CoV-2. Modeling the present, looking at the future",Physics Reports,07-28
7595696,"design, retrosynthetic analysis and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2",Biology Open,10-19
7426542,Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression,Physiology,08-12
7534368,SARS-CoV-2 spike produced in insect cells elicits high neutralization titresin non-human primates,Emerging Microbes & Infections,09-24
7473028,"RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19",Biochemical and Biophysical Research Communications,09-04
7438404,Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?,Frontiers in Microbiology,08-13
7712209,COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach,Vaccines,11-18
7665879,Peptide and peptide-based inhibitors of SARS-CoV-2 entry,Advanced Drug Delivery Reviews,11-13
7417167,Arrhythmias and COVID-19: A Review,Jacc. Clinical Electrophysiology,08-10
7568009,"A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2",Virologica Sinica,10-17
7557681,Bibliometric Analysis of Early COVID-19 Research: The Top 50 Cited Papers,Infectious Diseases,10-13
7520144,Cancer Care Management During the COVID-19 Pandemic,Risk Management and Healthcare Policy,09-23
7262330,"Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic",Journal of Medical Virology,04-27
7834013,Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection,European Journal of Pharmacology,07-31
7464215,Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management,Journal of Clinical Medicine,08-06
7773542,Novel coronavirus disease (COVID-19) pandemic: A recent mini review,Computational and Structural Biotechnology Journal,12-31
7556756,Antibody-like proteins that capture and neutralize SARS-CoV-2,Science Advances,10-14
7724622,COVID-19 and graft-versus-host disease: a tale of two diseases (and why age matters),Laboratory Investigation; a Journal of Technical Methods and Pathology,12-09
7767578,Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review,"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery",12-27
7480027,Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.,bioRxiv,09-04
7454055,"Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States",Emerging Infectious Diseases,09-01
7573101,"SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment",Frontiers in Immunology,10-06
7545136,Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2,Frontiers in Microbiology,09-25
7158889,Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate SevereAcute Respiratory Syndrome Coronavirus 2 Detection,ACS Nano,04-13
7445583,"Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19",Liver Research,08-25
7443081,"A comparison of COVID-19, SARS and MERS",PeerJ,08-19
7303432,Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms,Sn Comprehensive Clinical Medicine,06-19
7346800,Identification of correlated inter-residue interactions in protein complex based on the fragment molecular orbital method,Journal of Molecular Graphics & Modelling,07-09
7099673,Protein Structure and Sequence Reanalysis of 2019-nCoV GenomeRefutes Snakes as Its Intermediate Host and the Unique Similarity betweenIts Spike Protein Insertions and HIV-1,Journal of Proteome Research,03-22
7769135,Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins,Frontiers in Chemistry,12-10
7164391,A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV,"Science (New York, N.y.)",04-03
7482598,On the genetics and immunopathogenesis of COVID-19,"Clinical Immunology (Orlando, Fla.)",09-10
7688047,Bioengineered  Tissue Models to Study SARS-CoV-2Pathogenesis and Therapeutic Validation,ACS Biomaterials Science & Engineering,11-16
7586923,COVID-19 and the Kidney Community: Coalescing in Crisis,Advances in Chronic Kidney Disease,10-26
7573581,Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2,Scientific Reports,10-19
7523097,Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells,bioRxiv,09-16
7375388,"Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts",Journal of Virology,07-16
7832810,From ACE2 to COVID-19: A multiorgan endothelial disease,International Journal of Infectious Diseases,09-05
7404514,Cytokine storm syndrome in coronavirus disease 2019: A narrative review,Journal of Internal Medicine,07-22
7406419,Molecular diagnostic technologies for COVID-19: Limitations and challenges,Journal of Advanced Research,08-06
7481144,A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2,Journal of Structural Biology,09-10
7441399,COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside,NPJ Parkinson's Disease,08-20
7293453,Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model,"Chaos, Solitons, and Fractals",06-13
7311999,Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases,International Journal of Molecular Sciences,05-28
7054527,Transmission routes of 2019-nCoV and controls in dental practice,International Journal of Oral Science,03-03
7481450,Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response,Frontiers in Public Health,08-27
7448771,"A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations","Infection, Genetics and Evolution",08-26
7685702,Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration,eLife,10-26
7228328,Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults,"Acta Paediatrica (Oslo, Norway : 1992)",04-14
7115348,Coronavirus disease 2019 (COVID-19): a clinical update,Frontiers of Medicine,04-02
7601831,Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins,Viruses,09-29
7665328,MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs,Briefings in Bioinformatics,10-20
7264175,Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients,Nature Communications,06-01
7675408,"Analysis of SARS‐CoV‐2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis",Journal of Medical Virology,11-01
7544927,Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia,Journal of Biomolecular Structure & Dynamics,09-16
7337393,SARS-CoV-2 Simulations Go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome,bioRxiv,10-07
7744920,The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin: SARS‐COV‐2 chimeric structure and furin cleavage site might be the result of genetic manipulation,Bioessays,11-17
7334623,Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus,Cellular and Molecular Neurobiology,07-04
7815659,Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan,Biochemistry and Biophysics Reports,12-29
7594187,Deep mutagenesis in the study of COVID-19: a technical overview for the proteomics community,Expert Review of Proteomics,10-21
7384993,The SARS-CoV-2 and mental health: From biological mechanisms to social consequences,Progress in Neuro-Psychopharmacology & Biological Psychiatry,07-28
7710271,"Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors",JCI Insight,11-19
7471434,Single-particle virology,Biophysical Reviews,09-03
7605563,SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility,bioRxiv,10-27
7366957,Inhibiteurs du système rénine-angiotensine au cours de la COVID-19 : protecteurs ou dangereux ?,Archives Des Maladies du Coeur et Des Vaisseaux. Pratique,07-17
7351523,Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity,Frontiers in Cell and Developmental Biology,07-03
7743087,"IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10",medRxiv,12-07
7370857,Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?,"Arteriosclerosis, Thrombosis, and Vascular Biology",06-08
7129862,Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019,Mayo Clinic Proceedings,04-04
7402212,The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status,Journal of Infection and Public Health,08-04
7753008,Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics,Frontiers in Cellular and Infection Microbiology,12-08
7266513,Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism,Neuropsychiatric Disease and Treatment,05-28
7577366,analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2,3 Biotech,10-21
7457616,A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice,bioRxiv,08-28
7554795,Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies,International Journal of Molecular Sciences,09-16
7267377,Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models,European Journal of Neurology,05-22
7322478,Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective,Biophysical Chemistry,06-29
7310626,Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding,bioRxiv,06-17
7688049,Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State ofthe Art and Future Opportunities,Journal of Medicinal Chemistry,11-13
7349555,Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19,Vaccines,05-14
7302282,Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome,medRxiv,06-07
7473411,The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector,Molecular Biology,09-04
7224615,Transmission electron microscopy imaging of SARS-CoV-2,The Indian Journal of Medical Research,04-28
7315709,Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis,Annals of Gastroenterology,06-06
7142693,A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2,Cell Host & Microbe,03-16
7263504,A single-cell RNA expression map of human coronavirus entry factors,bioRxiv,05-17
7693583,Osmotic Adaptation by Na-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19,Biomedicines,10-30
7447089,Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure,Heart Failure Reviews,08-25
7523095,The flexibility of ACE2 in the context of SARS-CoV-2 infection,bioRxiv,09-16
7302215,Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes,bioRxiv,05-30
7232198,"Virology, Epidemiology, Pathogenesis, and Control of COVID-19",Viruses,03-27
7419326,Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein,Computational and Structural Biotechnology Journal,08-12
7705366,Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery,Computers in Biology and Medicine,12-01
7406073,Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain,PLoS ONE,08-05
7467124,"Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route",Medical Hypotheses,09-02
7794970,The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities,Molecules,12-31
7256035,Universal coronavirus vaccines: the time to start is now,NPJ Vaccines,05-28
7773528,Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations,European Journal of Pharmacology,12-31
7523138,SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy,medRxiv,09-18
7501876,Primed for global coronavirus pandemic: Emerging research and clinical outcome,European Journal of Medicinal Chemistry,09-19
7159850,Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science,The Lancet. Psychiatry,04-15
7523240,Beyond Shielding: The Roles of Glycans in the SARS-CoV-2Spike Protein,ACS Central Science,09-23
7598940,Emerging treatment strategies for COVID-19 infection,Clinical and Experimental Medicine,10-30
7258854,SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention,Biochimie,05-29
7605337,Critical Sequence Hotspots for Binding of Novel Coronavirus toAngiotensin Converter Enzyme as Evaluated by MolecularSimulations,The Journal of Physical Chemistry. B,10-28
7441802,On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity,Journal of Biomolecular Structure & Dynamics,07-09
7799362,Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection,EMBO Molecular Medicine,11-30
7250776,El SRAA y el SARS-CoV-2: el acertijo a resolver,Hipertension Y Riesgo Vascular,05-27
7408018,Canonical and Noncanonical Autophagy as Potential Targets for COVID-19,Cells,07-05
7652413,ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities,eLife,11-09
7334499,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,Proceedings of the National Academy of Sciences of the United States of America,06-10
7538999,Inference of person-to-person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase,Nature Communications,10-06
7219847,Coronavirus Disease–Activated Emergency Scaling of Anesthesiology Responsibilities Intensive Care Unit,Anesthesia and Analgesia,05-07
7565639,Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein,Journal of Virology,10-14
7836322,Druggable targets from coronaviruses for designing new antiviral drugs,Bioorganic & Medicinal Chemistry,09-08
7779597,"Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct",Frontiers in Bioengineering and Biotechnology,12-21
7523109,Common genetic variation in humans impacts  susceptibility to SARS-CoV-2 infection,bioRxiv,09-21
7321661,Beyond protein structure determination with MicroED,Current Opinion in Structural Biology,06-28
7701093,In Search of Herbal Anti-SARS-Cov2 Compounds,Frontiers in Plant Science,11-16
7675606,Is vitamin D deficiency a risk factor for COVID‐19 in children?,Pediatric Pulmonology,10-13
7137402,COVID-19 and the RAAS—a potential role for angiotensin II?,Critical Care,04-07
7305492,Where are we with understanding of COVID-19?,Advances in Biological Regulation,06-20
7654858,The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition,bioRxiv,11-03
7675327,Using student‐centered approaches to teach the biochemistry of ‐2,Biochemistry and Molecular Biology Education,10-14
7260597,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",Travel Medicine and Infectious Disease,05-30
7497736,Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection,International Journal of Infectious Diseases,09-17
7558244,Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients,Stem Cell Research & Therapy,10-15
7737537,COVID-19: The Effect of Host Genetic Variations on Host–VirusInteractions,Journal of Proteome Research,12-10
7232010,‐CoV‐2 receptor 2 and 2 are primarily expressed in bronchial transient secretory cells,The EMBO Journal,04-14
7262247,Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered questions,Journal of Thrombosis and Haemostasis,05-06
7548336,The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19),Therapeutics and Clinical Risk Management,10-07
7303615,Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike,Cell Host & Microbe,06-19
7350702,COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning,Frontiers in Immunology,07-03
7314067,Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study,European Heart Journal,06-04
7195166,More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19,Journal of Molecular and Cellular Cardiology,04-06
7237921,Covid-19 Pandemic and Current Medical Interventions,Archives of Medical Research,05-20
7544970,Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection,Expert Review of Vaccines,09-24
7241100,Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein,bioRxiv,05-16
7544555,Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19,The Protein Journal,10-09
7761721,Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients,Viruses,12-03
7293463,"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach",Biochimica et Biophysica Acta. Molecular Basis of Disease,06-13
7239070,Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients,medRxiv,04-24
7377801,Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment,Journal of Molecular Graphics & Modelling,07-23
7332230,Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province,Journal of Medical Internet Research,06-30
7834210,Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting,European Journal of Pharmacology,07-31
7238035,"Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)",Pathogens,04-22
7430580,Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike,bioRxiv,08-10
7534791,Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh,International Journal of Infectious Diseases,10-05
7753152,Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies,Frontiers in Medicine,12-08
7194977,Coronavirus membrane fusion mechanism offers a potential target for antiviral development,Antiviral Research,04-06
7149306,Mit Immanuel Kant in die zweite Welle der gegenwärtigen Pandemie,Prävention und Gesundheitsförderung,04-08
7102657,Advance of promising targets and agents against COVID-19 in China,Drug Discovery Today,03-18
7509820,Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic,Infectious Agents and Cancer,09-23
7273117,Impact of glycoscience in fighting Covid-19,Glycoconjugate Journal,06-05
7525006,Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System,Frontiers in Cell and Developmental Biology,09-16
7243793,Chemistry and Biology of SARS-CoV-2,Chem,05-22
7196923,"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment",Journal of Biomolecular Structure & Dynamics,04-30
7412777,Management and Reconfiguration of a Radiology Department under the Threat of Coronavirus Disease 2019: Experience from Wuhan,Current Medical Science,08-07
7360742,SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses,Nature Communications,07-14
7480773,Environmental impacts on the transmission and evolution of COVID-19 combing the knowledge of pathogenic respiratory coronaviruses,"Environmental Pollution (Barking, Essex : 1987)",09-09
7528898,Facile biosensors for rapid detection of COVID-19,Biosensors & Bioelectronics,10-01
7687367,Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity,Immunity,11-25
7711057,Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines,Molecular Biomedicine,12-03
7243912,Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors,Future Virology,05-21
7409923,Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by DistalPolybasic Cleavage Sites,ACS Nano,08-02
7103893,The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients,Inflammation Research,03-29
7256909,Why Italian ENT physicians should be aware of SARS-CoV-2,Acta Otorhinolaryngologica Italica,03-31
7239046,Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections,bioRxiv,03-17
7509271,Diabetes and COVID-19 risk: an miRNA perspective,American Journal of Physiology - Heart and Circulatory Physiology,08-07
7393674,Fragile Endothelium and Brain Dysregulated NeurochemicalActivity in COVID-19,ACS Chemical Neuroscience,07-27
7563688,Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design,Vaccines,07-03
7404502,COVID‐19 and hydatidiform mole,American Journal of Reproductive Immunology,08-04
7527437,Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective,Frontiers in Immunology,09-17
7152870,The clinical course and its correlated immune status in COVID-19 pneumonia,Journal of Clinical Virology,04-12
7527296,How COVID-19 induces cytokine storm with high mortality,Inflammation and Regeneration,10-01
7833040,Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection,Journal of Traditional and Complementary Medicine,12-29
7217786,Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season,Microbes and Infection,05-13
7672035,Rapid Response Subunit Vaccine Design in the Absence of Structural Information,Frontiers in Immunology,11-04
7673215,Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19,Gene,11-18
7751257,Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection,mBio,12-11
7567667,Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity,International Journal of Infectious Diseases,10-17
7382329,"Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses",Cellular and Molecular Life Sciences,07-25
7350358,Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations,Pathogens,06-20
7194921,Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites,Acta Pharmaceutica Sinica. B,04-20
7418655,Peripheral facial paralysis as presenting symptom of COVID-19 in a pregnant woman,BMJ Case Reports,08-11
7347906,Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy,Frontiers in Microbiology,07-03
7363601,SARS-CoV-2 and the cardiovascular system,Clinica Chimica Acta; International Journal of Clinical Chemistry,07-16
7554472,Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity,Immunity,10-14
7284156,Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening,Journal of Biomolecular Structure & Dynamics,06-02
7524381,"Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation",Molecular Diversity,09-29
7448777,Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients,Clinical Biochemistry,08-26
7271859,Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays,Protein Expression and Purification,06-04
7538685,The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection,Frontiers in Cellular and Infection Microbiology,09-23
7722245,Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue,Der Ophthalmologe,12-08
7199691,The role of ACEIs/ARBs in COVID-19: Friend or foe?,Medical Hypotheses,05-05
7769706,Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2,Journal of Structural Biology,12-29
7464057,Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19,Signal Transduction and Targeted Therapy,09-02
7668738,"Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome",bioRxiv,11-09
7640986,Molecular Basisof SARS-CoV-2 Infection and Rational Design of Potential AntiviralAgents: Modeling and Simulation Approaches,Journal of Proteome Research,10-29
7537138,"SARS‐CoV‐2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors",The FASEB Journal,09-23
7810037,Robust neutralizing antibodies to SARS-CoV-2 infection persist for months,"Science (New York, N.y.)",10-28
7289711,The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin,Signal Transduction and Targeted Therapy,06-12
7390283,Developing a low-cost and accessible COVID-19 vaccine for global health,PLoS Neglected Tropical Diseases,07-29
7392438,"Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USA",Emerging Infectious Diseases,08-01
7775388,A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters,Frontiers in Immunology,12-18
7369003,Withaferin A: a potential therapeutic agent against COVID-19 infection,Journal of Ovarian Research,07-19
7762468,Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic,Aging (Albany NY),11-10
7238102,"Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options",Pathogens,04-17
7282418,Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome,Osong Public Health and Research Perspectives,06-01
7687410,Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays,Protein Expression and Purification,11-25
7236707,Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide,Mayo Clinic Proceedings,05-19
7606273,Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition,Frontiers in Microbiology,10-20
7197627,"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options",Cardiovascular Research,04-30
7327402,Clinical Characteristics of Children with COVID-19,AIMS Public Health,05-06
7516028,"Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses",Frontiers in Immunology,09-11
7340039,Pandemic COVID-19: Current status and challenges of antiviral therapies,Genes & Diseases,07-07
7605809,Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease,Prostaglandins & Other Lipid Mediators,11-02
7784661,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2,Bioconjugate Chemistry,12-24
7756312,Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models,Genome Biology,12-23
7378008,Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors,"Infection, Genetics and Evolution",07-24
7547067,The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV,Scientific Reports,10-09
7314683,Mask use during COVID-19: A risk adjusted strategy,"Environmental Pollution (Barking, Essex : 1987)",06-25
7433338,Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than DoesSARS-CoV?,The Journal of Physical Chemistry. B,07-29
7537968,Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review,Critical Care,10-06
7441891,Immunotherapeutic approaches to curtail COVID-19,International Immunopharmacology,08-21
7332915,Natural history of COVID-19 and current knowledge on treatment therapeutic options,Biomedicine & Pharmacotherapy,07-03
7269891,Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility,Journal of Biosciences,06-04
7466451,"Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19",Frontiers in Pharmacology,08-19
7584396,Potently neutralizing and protective human antibodies against SARS-CoV-2,Nature,07-15
7167584,A short review on antibody therapy for COVID-19,New Microbes and New Infections,04-20
7591699,A Review of the Progress and Challenges of Developing a Vaccine for COVID-19,Frontiers in Immunology,10-14
7162686,Saliva: potential diagnostic value and transmission of 2019-nCoV,International Journal of Oral Science,04-17
7472674,"COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics",Infection,09-04
7707962,"SARS-CoV-2, Early Entry Events",Journal of Pathogens,11-24
7483421,Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain,Nature Communications,09-10
7486227,Respiratory disease in rhesus macaques inoculated with SARS-CoV-2,Nature,05-12
7314187,Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019,Clinical Kidney Journal,06-06
7489885,Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy,Cell,09-14
7491531,"Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts",medRxiv,09-11
7533376,Alteration in angiotensin-converting enzyme 2 by PM during the development of emphysema in rats,ERJ Open Research,10-05
7568848,Renin-angiotensin system at the interface of COVID-19 infection,European Journal of Pharmacology,10-18
7428439,Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19),Gene,08-15
7604136,Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2,Cell,10-31
7455167,Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends,International Journal of Infectious Diseases,08-28
7325192,SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?,Immunity & Ageing : I & A,06-30
7264370,Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation,Frontiers in Pharmacology,05-26
7674982,Smoking and COVID-19: What we know so far,Respiratory Medicine,11-19
7705946,Renal Injury by SARS-CoV-2 Infection: A Systematic Review,Kidney Diseases,11-16
7315998,Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal,medRxiv,06-23
7724984,"Airborne Transmission of COVID-19: Aerosol Dispersion, LungDeposition, and Virus-Receptor Interactions",ACS Nano,11-25
7521409,Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics,Gene Reports,09-28
7677677,Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection,Chemical Engineering Journal,11-20
7759334,Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study,Virology,12-24
7537730,Involvement of the nervous system in COVID-19: The bell should toll in the brain,Life Sciences,10-06
7241112,COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?,The European Respiratory Journal,07-16
7575906,"The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens",Frontiers in Immunology,10-07
7536205,SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals,Scientific Reports,10-05
7523099,Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines,bioRxiv,09-14
7537550,Development of a Parallel Reaction Monitoring Mass SpectrometryAssay for the Detection of SARS-CoV-2 Spike Glycoprotein andNucleoprotein,Analytical Chemistry,09-23
7144807,COVID-19: A Call for Physical Scientists and Engineers,ACS Nano,04-08
7408943,Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis,Journal of Clinical Medicine,06-29
7311918,Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies,Cell,06-24
7217288,Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition,bioRxiv,05-01
7366953,Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2,Genes & Diseases,07-17
7654302,A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum,Journal of Molecular Liquids,11-10
7587116,SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients,Journal of Clinical Microbiology,10-21
7196426,The pathogenesis and alternative treatment of SARS-CoV2,Integrative Medicine Research,05-03
7231734,Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections,Cell Reports,05-18
7399080,Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?,Frontiers in Immunology,07-28
7255727,Coronavirus 2019 (COVID-19)–Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience,World Neurosurgery,05-28
7569100,Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm,Biophysics,10-19
7350707,"While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?",Frontiers in Physiology,07-03
7498473,COVID-2019 – A comprehensive pathology insight,"Pathology, Research and Practice",09-18
7402113,COVID-19 and the central nervous system,Clinical Neurology and Neurosurgery,08-04
7224157,Identification of Human Single-Domain Antibodies against SARS-CoV-2,Cell Host & Microbe,05-14
7542548,A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma,The American Journal of Case Reports,10-03
7640959,METATRYP v 2.0:Metaproteomic Least Common AncestorAnalysis for Taxonomic Inference Using Specialized Sequence Assemblies—StandaloneSoftware and Web Servers for Marine Microorganisms and Coronaviruses,Journal of Proteome Research,09-08
7561517,Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain,Informatics in Medicine Unlocked,10-16
7834266,"In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex",Results in Chemistry,12-28
7484578,Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding,Journal of Biomolecular Structure & Dynamics,08-27
7116727,Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion,Nature,09-17
7553054,Prepandemic Preparedness under the Spotlight at ASGCT’s COVID-19 Symposium,Molecular Therapy,10-13
7156150,Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease,Academic Radiology,03-20
7258639,COVID-19 with Different Severities: A Multicenter Study of Clinical Features,American Journal of Respiratory and Critical Care Medicine,06-01
7237916,IL-6: Relevance for immunopathology of SARS-CoV-2,Cytokine & Growth Factor Reviews,05-20
7670261,COVID-19 and stroke: A review,Brain Hemorrhages,11-17
7451412,Genetic and pathogenic characterization of SARS-CoV-2: a review,Future Virology,08-26
7242186,SARS-CoV-2 and diabetes: New challenges for the disease,Diabetes Research and Clinical Practice,05-22
7277967,Saliva—Friend and Foe in the COVID-19 Outbreak,Diagnostics,05-09
7757413,Manipulation of ACE2 expression in COVID-19,Open Heart,12-22
7331935,Role of RNA Guanine Quadruplexes in Favoring the Dimerization ofSARS Unique Domain in Coronaviruses,The Journal of Physical Chemistry Letters,06-14
7239052,Rapid community-driven development of a SARS-CoV-2 tissue simulator,bioRxiv,07-29
7352091,"Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications",Sn Comprehensive Clinical Medicine,07-11
7396141,"SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus",Travel Medicine and Infectious Disease,08-02
7587547,Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review,The Protein Journal,10-26
7691136,Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2,"Infection, Genetics and Evolution",11-27
7413717,Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review,Infection and Drug Resistance,08-03
7236830,Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review,The European Respiratory Journal,07-09
7198537,A human monoclonal antibody blocking SARS-CoV-2 infection,Nature Communications,05-04
7462334,The Cellular basis of loss of smell in 2019-nCoV-infected individuals,Briefings in Bioinformatics,08-18
7649901,Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2,In Silico Pharmacology,11-09
7823979,"Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations",Viruses,12-30
7214348,Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights,Journal of Stroke and Cerebrovascular Diseases,05-12
7642744,SARS-CoV-2 Attachment to Host Cells is Possibly Mediated via RGD-Integrin Interaction in a Calcium-dependent Manner and Suggests Pulmonary EDTA Chelation Therapy as a Novel Treatment for COVID 19,Immunobiology,11-05
7347485,Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions,Antiviral Research,07-10
7313652,Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication,Acta Pharmacologica Sinica,06-24
7390782,"In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection",International Journal of Antimicrobial Agents,07-30
7167496,Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor,Cellular and Molecular Immunology,04-20
7314941,Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience,Frontiers in Neurology,06-18
7441380,Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide,Scientific Reports,08-20
7402319,Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation,International Journal of Molecular Sciences,07-11
7480855,Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma,PLoS ONE,09-09
7679512,Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution?,Medical Hypotheses,11-21
7338099,Hepatitis C virus vaccine design: focus on the humoral immune response,Journal of Biomedical Science,07-06
7423510,COVID-19 Vaccine: A comprehensive status report,Virus Research,08-13
7381773,Molecular Basis for Pathogenicity of Human Coronaviruses,Infection and Drug Resistance,07-17
7765555,SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure,Journal of Clinical Medicine,12-15
7178925,Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening,European Journal of Clinical Microbiology & Infectious Diseases,04-23
7217129,Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO—A “Living Working Document”,Asaio Journal,04-30
7700729,"The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities","Infection, Genetics and Evolution",11-29
7216271,A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2,International Journal of Molecular Sciences,04-18
7336722,Treating a Global Health Crisis with a Dose of SyntheticChemistry,ACS Central Science,06-30
7311344,Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options,Molecular Therapy. Methods & Clinical Development,06-24
7584308,COVID-19: The Impact in Oncology Care,Sn Comprehensive Clinical Medicine,10-23
7696831,Spike Glycoprotein-Mediated Entry of SARS Coronaviruses,Viruses,11-11
7156162,Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence,International Journal of Antimicrobial Agents,03-19
7753443,Prefusion spike protein stabilization through computational mutagenesis,Proteins,12-04
7707640,D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization,Cell Host & Microbe,12-01
7319274,Structure-based drug designing and immunoinformatics approach for SARS-CoV-2,Science Advances,06-24
7516384,The potential role of the carotid body in COVID-19,American Journal of Physiology - Lung Cellular and Molecular Physiology,08-05
7537046,"The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus",Reviews in Medical Virology,09-18
7598569,The nervous system—A new territory being explored of SARS-CoV-2,Journal of Clinical Neuroscience,10-28
7589479,Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays,Cell Discovery,10-27
7700767,ACE2 partially dictates the host range and tropism of SARS-CoV-2,Computational and Structural Biotechnology Journal,11-29
7546461,Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19,PLoS Pathogens,10-09
7462603,Peptides to combat viral infectious diseases,Peptides,09-01
7443814,Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2),Journal of Translational Medicine,08-24
7332438,Diabetes and COVID-19: Global and regional perspectives,Diabetes Research and Clinical Practice,07-03
7568239,Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation,Proceedings of the National Academy of Sciences of the United States of America,09-28
7291771,Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections,Frontiers in Microbiology,06-05
7753271,Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review,Journal of Medical Virology,12-17
7523096,Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection,bioRxiv,09-23
7695547,Thermal Inactivation Scaling Applied for SARS-CoV-2,Biophysical Journal,11-28
7373339,"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections",Journal of Neuroimmune Pharmacology,07-21
7772798,Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants,Journal of Translational Medicine,12-30
7784827,Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses,Current Medical Research and Opinion,12-26
7430605,Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera,medRxiv,08-27
7367004,Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review,Phytomedicine,07-17
7807638,"Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review)",Experimental and Therapeutic Medicine,12-17
7299281,Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability,"Science (New York, N.y.)",06-15
7747004,Viral targets for vaccines against COVID-19,Nature Reviews. Immunology,12-18
7462717,Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development,Journal of Laboratory Physicians,09-01
7654750,Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection,The Journal of General Virology,06-15
7310628,"Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis",bioRxiv,06-17
7544960,COVID-19: benefits and risks of passive immunotherapeutics,Human Vaccines & Immunotherapeutics,09-22
7836551,Furin cleavage sites naturally occur in coronaviruses,Stem Cell Research,12-09
7308495,Neuromechanisms of SARS-CoV-2: A Review,Frontiers in Neuroanatomy,06-16
7812826,DeepTracer for fast de novo cryo-EM protein structure modeling and special studies on CoV-related complexes,Proceedings of the National Academy of Sciences of the United States of America,12-23
7236689,"Diagnosis and treatment of emergency surgeries in otorhinolaryngology, head and neck surgery during the covid-19 outbreak: A single center experience",World Journal of Otorhinolaryngology - Head and Neck Surgery,05-19
7461420,The recent outbreaks of human coronaviruses: A medicinal chemistry perspective,Medicinal Research Reviews,08-27
7219397,The Challenges of Vaccine Development against a New Virus during a Pandemic,Cell Host & Microbe,05-13
7245327,High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2,The Journal of Investigative Dermatology,05-23
7094976,Insights from nanomedicine into chloroquine efficacy against COVID-19,Nature Nanotechnology,03-23
7857395,Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms,"Science (New York, N.y.)",09-24
7414235,The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19,American Journal of Physiology - Gastrointestinal and Liver Physiology,07-08
7322019,Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions,Proceedings of the National Academy of Sciences of the United States of America,06-05
7458058,Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2,Cytotherapy,08-31
7404873,Atomistic simulation reveals structural mechanisms underlying  spike glycoprotein‐enhanced fitness in ‐2,Journal of Computational Chemistry,07-21
7146689,Nervous system involvement after infection with COVID-19 and other coronaviruses,"Brain, Behavior, and Immunity",03-30
7772528,Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection,Biochemistry. Biokhimiia,12-30
7534972,"Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19",Revista da Sociedade Brasileira de Medicina Tropical,10-05
7343451,design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2,Aging (Albany NY),06-16
7522797,The Potential of Antiviral Peptides as COVID-19 Therapeutics,Frontiers in Pharmacology,09-15
7553041,COVID-19 Vaccine Frontrunners and Their Nanotechnology Design,ACS Nano,10-09
7164888,COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities,Jacc. Cardiooncology,04-17
7713605,COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine,Mayo Clinic Proceedings,12-03
7654909,Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model,medRxiv,11-05
7561359,The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19,Frontiers in Immunology,09-30
7511833,COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention,Frontiers in Neurology,09-10
7274265,Dysfunctional Coagulation in COVID-19: From Cell to Bedside,Advances in Therapy,06-05
7243216,COVID-19 Disease and Ophthalmology: AnUpdate,Ophthalmology and Therapy,05-22
7444679,"Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study",Journal of Human Hypertension,08-24
7235504,"SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup",Current Protocols in Microbiology,04-17
7704119,Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2,Genome Medicine,12-01
7680968,A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic,Frontiers in Endocrinology,11-09
7458444,Emergence of SARS-CoV-2 through recombination and strong purifying selection,Science Advances,07-01
7164635,Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2,"Science (New York, N.y.)",03-04
7267562,Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs,Febs Letters,05-25